Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Conference day 1

Monday, June 6th 2022

13:00 - 14:15, Main Arena 1

New solutions for complex aortoiliac obstructions

Moderator:

Dierk Scheinert

Panel:

Patrice Mwipatayi, Maria Antonella Ruffino, Peter Goverde, Eric Secemsky
1. 13:00 - 13:15
  
  Live case transmission from Leipzig – part I
2. 13:15 - 13:20
  
  Use and effectiveness of Pioneer re-entry device for subintimal true lumen re-entry: Single-centre data and a review of the literature
3. 13:20 - 13:25
  
  Initial interim results from the post-market registry of the GORE® VIABAHN® VBX balloon expandable endoprosthesis implanted in peripheral vessels
4. 13:25 - 13:30
  
  Following up patients with iliac occlusive disease treated with the GORE® VIABAHN® VBX balloon expandable endoprosthesis – FLEX clinical study
5. 13:30 - 13:35
  
  Outcomes of self-expanding e-PTFE covered stent when treating chronic iliac artery occlusions – a multi-centre experience
6. 13:35 - 13:45
  
  Live case transmission from Leipzig – part II
7. 13:45 - 13:50
  
  Versatility of covered stents in complex aorto-iliac POD lesions and FEVAR/BEVAR
8. 13:50 - 13:55
  
  FIRST TIME DATA RELEASE: BELSTREAM – 12-month results of study
9. 13:55 - 14:00
  
  5-year follow-up of CERAB reconstructions: Single center experience from the Netherlands
10. 14:00 - 14:05
  
  Multicentre experience on CERAB technique for the treatment option of AIOD – Polish experiences
11. 14:05 - 14:10
  
  Improving outcomes of vascular interventions with AI
12. 14:10 - 14:15
  
  Advances in intravascular imaging: Real world evidence and expert consensus
13:00 - 14:00, Main Arena 2

Carotid revascularisation – what is new in 2022?

Moderator:

Horst Sievert

Panel:

Alison Halliday, Piero Montorsi, Frans Moll, Murat Muzaffer Guclu
1. 13:00 - 13:05
  
  Quality assessment of carotid reconstruction – anything new from the German registry?
2. 13:05 - 13:10
  
  ACST II-trial: Update on latest data and clinical implications
3. 13:10 - 13:20
  
  Proximal protection in CAS: the right way to go?
4. 13:20 - 13:25
  
  Improving your safety profile through proximal protection: Experiences from a high volume carotid artery stenting center
5. 13:25 - 13:50
  
  Live case transmission from Milan
6. 13:50 - 13:55
  
  TCAR: Patient selection, technique, and role in contemporary practice
7. 13:55 - 14:00
  
  CAS in patients with bovine and Type III arch – a single center experience
14:00 - 15:15, Main Arena 2

Carotid stenosis treatment: Is the puzzle complete?

supported by Terumo

Moderator:

Sasko Kedev

Panel:

Richard Bulbulia, Zsolt Vajda, Koen Deloose
1. 14:00 - 14:03
  
  Introduction
2. 14:03 - 14:13
  
  Asymptomatic carotid stenosis treatment: Lessons from > 6000 randomized patients in AST 1 and 2
3. 14:13 - 14:33
  
  Live case transmission from Münster
4. 14:33 - 14:43
  
  ROADSAVER study outcomes: Real-world evidence from a large carotid stenting cohort treated with a dual-layer micromesh stent
5. 14:43 - 14:58
  
  Live in a box from Milan
6. 14:58 - 15:08
  
  Pieces of puzzle coming together, building a new carotid treatment algorithm
7. 15:08 - 15:15
  
  Q&A, discussion, and conclusion
14:15 - 15:15, Main Arena 1

Opening Symposium: Focus on the lower limb: Novel treatment options from SFA to BTK

supported by Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Luis Palena, Michael Lichtenberg, Houman Jalaie, Lieven Maene
1. 14:15 - 14:17
  
  Welcome from the moderator
2. 14:17 - 14:29
  
  Late breaker: 2 year follow-up of SUPERSUB II
3. 14:29 - 14:34
  
  Discussion
4. THROMBECTOMY: THE BENEFITS OF MECHANICAL THROMBECTOMY FOR LOWER LIMB TREATMENT
5. 14:34 - 14:39
  
  Treating acute limb ischemia with mechanical thrombectomy – case presentation
6. 14:39 - 14:46
  
  Mechanical thrombectomy for venous thromboembolism: A pathway to consider?
7. 14:46 - 14:51
  
  Treating venous thromboembolism with mechanical thrombectomy – case presentation
8. 14:51 - 14:58
  
  Discussion
9. 14:58 - 15:08
  
  Tomorrow’s BTK treatment options – drug eluting resorbable scaffolds
10. 15:08 - 15:13
  
  Discussion
11. 15:13 - 15:15
  
  Take-home messages
15:15 - 16:30, Main Arena 1

Novel approaches and insights for treatment of complex femoropopliteal disease – part I

Moderator:

Thomas Zeller, Peter Schneider

Panel:

Gary Ansel, Koen Deloose, Robert Beasley, Erwin Blessing, Rokas Gircius, Peter Metzger
1. 15:15 - 15:20
  
  Serration angioplasty technique for better lumen gain
2. 15:20 - 15:30
  
  RECORDED CASE PRESENTATION: Serranator Serration balloon as primary therapy for CLTI disease
3. 15:30 - 15:35
  
  FIRST TIME DATA RELEASE: UltraScore – final results of a multi-center study
4. 15:35 - 15:40
  
  FIRST TIME DATA RELEASE: Long-term evidence of directonal atherectomy and DCB: 3-year clinical experience from Australia
5. 15:40 - 15:45
  
  Clinical outcomes with drug-coated balloon alone vs. drug-coated balloon plus provisional stenting: An analysis from the IN.PACT global study 5-year data
6. 15:45 - 15:50
  
  BIOPACT RCT: A head-to-head multicenter noninferiority trial of the safety and efficacy of Passeo-18 Lux vs. In.Pact Admiral DCBs in fempop lesions
7. 15:50 - 16:05
  
  Live case transmission from Bad Krozingen
8. 16:05 - 16:15
  
  FIRST TIME DATA RELEASE: Cost-effectiveness of urea excipient-based drug-coated balloons for chronic limb-threatening ischemia from femoropopliteal disease
9. 16:15 - 16:20
  
  5-year results from the Lutonix trial
10. 16:20 - 16:25
  
  IN.PACT global study 5-year diabetic and gender subgroup outcomes
11. 16:25 - 16:30
  
  Recent data outcomes in complex femoropopliteal occlusive disease with the GORE® VIABAHN® Endoprosthesis
15:15 - 15:50, Main Arena 2

Innovative options for patients with end-stage renal disease: Percutaneous creation of AV-access

Moderator:

Dimitrios Karnabatidis, Ounali Jaffer

Panel:

Jeffrey Hull, Robert Shahverdyan, Jackie Ho
1. 15:15 - 15:20
  
  Multi-center experience with WavelinQ™ 4F in 120 patients
2. 15:20 - 15:25
  
  Patient perspective of EndoAVF – insights from a multi-center analysis
3. 15:25 - 15:30
  
  Single-center experience with WavelinQ™ 4F
4. 15:30 - 15:35
  
  Implications of anatomic variations for EndoAVF
5. 15:35 - 15:40
  
  AVF creation using Ellipsys: Long-term evidence to date
6. 15:40 - 15:45
  
  AVF creation: Comparing surgical and percutaneous outcomes
7. 15:45 - 15:50
  
  FIRST TIME DATA RELEASE: Arteriovenous access creation: Updates from the Hamburg experience
15:50 - 17:05, Main Arena 2

Are we stenting too little, too late? An introduction to the WRAPSODY™ cell-impermeable endoprosthesis and 12-month data

supported by Merit Medical

Moderator:

Fabrizio Fanelli

Panel:

Dheeraj Rajan, Katarzyna Kolasa, Tobias Steinke, Ounali Jaffer
1. 15:50 - 15:53
  
  Introduction by the moderator
2. 15:53 - 16:04
  
  The evolution of covered stents
3. 16:04 - 16:16
  
  Live case transmission from Varese
4. 16:16 - 16:27
  
  Clinical trials: WRAPSODY™ FIRST, IDE, and registry
5. 16:27 - 16:39
  
  Recorded case presentation
6. 16:39 - 16:50
  
  The algorithm for covered stent treatment
7. 16:50 - 17:00
  
  Health economics in covered stent management: An overview
8. 17:00 - 17:05
  
  Final Q&A and wrap up
16:00 - 17:15, Speakers Corner

Latest results from clinical trials and innovations: Carotid/Venous/AV

Moderator:

Manuela Konert, Daniela Branzan
1. 16:00 - 16:05
  
  30-day safety outcomes of patients treated with the Roadsaver dual-layer micromesh carotid artery stent via radial or femoral access route: Evidence from a large multicentre European study (ROADSAVER)
2. 16:05 - 16:10
  
  Intravascular lithotripsy (IVL) as new tool in calcified carotid arteries stenosis. Single center experience – LITO–ARCH registry
3. 16:10 - 16:15
  
  30-day safety outcomes of patients <75 and ≥75 years of age treated with the Roadsaver dual-layer micromesh carotid artery stent: Evidence from a large multicentre European study (ROADSAVER)
4. 16:15 - 16:20
  
  Randomized controlled trial of a first-generation carotid stent vs. the micronet-covered stent: 12-month outcomes
5. 16:20 - 16:25
  
  Mechanical thrombectomy for deep vein thrombosis in real-world patients: 6-month outcomes from the CLOUT registry
6. 16:25 - 16:30
  
  Prospective post-market clinical follow-up study of the endovascular thrombectomy system Aspirex.S in the treatment of acute venous occlusions
7. 16:30 - 16:35
  
  Patient selection in NIVL and tips to prevent migration
8. 16:35 - 16:40
  
  Abdominal Vascular Compression Syndromes (AVCS): Comprehensive evaluation of Median Arcuate Ligament, Nutcracker, May-Thurner, Superior Mesenteric Artery, and Pelvic Venous Congestion Syndromes and intervention algorithm based on interconnectivity of these syndromes
9. 16:40 - 16:45
  
  Conversion of arterio-venous access of hemodialysis to arterio-arterial access for treatment of venous hypertension with central venous occlusion
10. 16:45 - 16:50
  
  Microwave ablation of varicose veins – early Egyptian experience
11. 16:50 - 16:55
  
  Will great saphenous vein crossectomy laser ablation be safer and more effective compared to the standard 2 cm distance from the valve laser ablation in management of primary varicose veins in Egypt?
12. 16:55 - 17:00
  
  SIroliMus coated angioPlasty vs. plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION (IMPRESSION)
13. 17:00 - 17:05
  
  Long term results of Supera in the AVF junta-anastomosis
14. 17:05 - 17:10
  
  Arteriovenous fistula formation with adjuvant endovascular maturation
15. 17:10 - 17:15
  
  Discussion and conclusion
16:30 - 17:15, Main Arena 1

Status of the SFA treatment paradigm

supported by COOK Medical

Moderator:

Koen Deloose

Panel:

Aloke Finn, Thomas Zeller, Osamu Iida, Marc Bosiers, E. Sebastian Debus
1. POLYMER-COATED DES: LEARN ABOUT THE EVIDENCE
2. 16:30 - 16:36
  
  Pre-clinical experience
3. 16:36 - 16:42
  
  Clinical experience
4. 16:42 - 16:48
  
  Clinical experience
5. 16:48 - 16:55
  
  Q&A, discussion
6. ADDITIONAL BENEFITS OF ENDOVASCULAR TREATMENT OVER BYPASS – READY TO MOVE ON?
7. 16:55 - 17:01
  
  Zilverpass – 36-month update and health economic snapshot
8. 17:01 - 17:07
  
  Should the endovascular approach be the new frontier?
9. 17:07 - 17:15
  
  Q&A, discussion, and conclusion
17:05 - 18:00, Main Arena 2

Advances in endovascular therapy of deep venous obstructions – part I: Advanced imaging modalities and first European experience with Opticross IVUS in complex venous disease

partially supported by Boston Scientific

Moderator:

Stephen Black

Panel:

Rutger Brans, Gerard O'Sullivan, Mahmood Razavi, Rick de Graaf, Tobias Hirsch
1. 17:05 - 17:10
  
  Pelvic vein anatomy and the use of ultrasound to classify the disease according to the 2021 SVP classification
2. 17:10 - 17:15
  
  The significance of accurate MR-venography before the treatment of iliofemoral thrombosis
3. 17:15 - 18:00
  
  Live case transmission from Modena
17:15 - 19:00, Main Arena 1

Novel approaches and insights for treatment of complex femoropopliteal disease – part II

Moderator:

Koen Deloose, Yann Gouëffic

Panel:

Marianne Brodmann, Antonio Micari, John Laird, Gireesh Mukund Warawdekar
1. 17:15 - 17:20
  
  Optimizing PTA following atherectomy in complex lower limb lesions: 12-month results of the DISSECT study
2. 17:20 - 17:25
  
  FIRST TIME DATA RELEASE: Treating common femoral artery steno-occlusive lesions with an endovascular approach using DA+DCB: 3-year follow-up in 75 patients
3. 17:25 - 17:45
  
  Live case transmission from Leipzig
4. 17:45 - 17:50
  
  Safety, effectiveness, and mid-term follow-up in 400 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy
5. 17:50 - 17:55
  
  Directional atherectomy (DA) followed by DCB to treat long, calcified femoropopliteal artery lesions: The REALITY study
6. 17:55 - 18:00
  
  EMINENT RCT (Eluvia vs. BMS): 12-month primary endpoint data and subset analysis
7. 18:00 - 18:05
  
  MIMICS-3D 3-year results: Compelling clinical outcomes with BioMimics 3D in complex patients and lesions
8. 18:05 - 18:10
  
  TINTIN trial 3-year follow-up
9. 18:10 - 18:40
  
  Live case transmission from Münster
10. 18:40 - 18:45
  
  FIRST TIME DATA RELEASE: Predictors of drug-coated balloon efficacy in femoropopliteal intervention: Insights from a patient-level pooled analysis
11. 18:45 - 18:50
  
  5-year results from the IN.PACT global study pre-specified cohorts: In-stent restenosis, chronic total occlusions, and long lesions
12. 18:50 - 18:55
  
  Safety and efficacy of Passeo-18 Lux in long lesions: Pooled results from the BIOLUX P-III and BIOLUX P-III Spain studies
13. 18:55 - 19:00
  
  Stellarex complex lesion subset analysis from the SAVER real world registry
18:00 - 19:00, Main Arena 2

Advances in endovascular therapy of deep venous obstructions – part II: Latest scientific data and new horizons

Moderator:

Rick de Graaf

Panel:

Rutger Brans, Gerard O'Sullivan, Kenneth Rosenfield
1. 18:00 - 18:05
  
  FIRST TIME DATA RELEASE: ABRE 24-month subgroup outcomes
2. 18:05 - 18:10
  
  VIVO 3-year data
3. 18:10 - 18:15
  
  VERNACULAR (Venovo) 3-year data
4. 18:15 - 18:20
  
  Venovo venous registry: 36-month data report from a real world registry
5. 18:20 - 18:25
  
  Preliminary data of multi-center RCT comparing venous stenting with conservative treatment in patients with deep venous obstructions
6. 18:25 - 18:30
  
  Anti-inflammation treatment for DVT
7. 18:30 - 18:40
  
  Recorded case presentation
8. 18:40 - 18:45
  
  Cost of venous leg ulcers related to deep venous disease and its implications
9. 18:45 - 18:50
  
  Deep venous obstruction and superficial reflux
10. 18:50 - 18:55
  
  Endovascular solutions in complex massive pulmonary embolism: When and how
11. 18:55 - 19:00
  
  Best practice for treatment of PE in 2022 – the role of endovascular therapy

Conference day 2

Tuesday, June 7th 2022

8:00 - 9:15, Main Arena 1

CONNECT THE WORLD JAPAN: Pioneering approaches for CTO treatment in peripheral arteries

partially supported by Boston Scientific

Moderator:

Dierk Scheinert, Hiroyoshi Yokoi

Panel:

Osamu Iida, Daizo Kawasaki, Koen Deloose, Ralf Langhoff

live from Tokyo:

Tatsuya Nakama

live from Leipzig:

Andrej Schmidt
1. FLASH PRESENTATION: The results from CAPSICUM multi-center registry of Eluvia DES in Japan
2. FLASH PRESENTATION: IVUS for peripheral interventions: Basic knowledge and tips and tricks
8:00 - 9:15, Main Arena 2

Interventional oncology: Hepatic interventions I

Moderator:

Ulf Teichgräber, Thomas J. Vogl

Panel:

Bernhard Gebauer, Maciej Pech, Michael Moche
1. 08:00 - 08:07
  
  Portal vein embolisation
2. 08:07 - 08:14
  
  Double venous embolization liver – interims results DRAGON 1 trial
3. 08:14 - 08:21
  
  Combined TACE and irreversible electroporation
4. 08:21 - 08:28
  
  Various products of radioembolization and its indications
5. 08:28 - 08:48
  
  Live case transmission from Jena
6. 08:48 - 08:55
  
  Diagnostic lymphography: Indications and techniques
7. 08:55 - 09:02
  
  Interventional lymphography: Techniques and results
8. 09:02 - 09:15
  
  Discussion and conclusion
8:30 - 9:45, Speakers Corner

Latest results from clinical trials and innovations

Moderator:

Thomas Zeller, Angelo Cioppa
1. 08:30 - 08:35
  
  Comparing results of the EX-PAD-03 IDE study and the PATHFINDER post-market registry evaluating the safety and efficacy of the Auryon laser atherectomy system
2. 08:35 - 08:40
  
  BIO REACT pilot study: 12-month outcomes
3. 08:40 - 08:45
  
  Treatment of ISR lesions with the Pantheris atherectomy catheter
4. 08:45 - 08:50
  
  Stent monitoring with the vessel sense flow measurement
5. 08:50 - 08:55
  
  Hemodynamic assessment of peripheral artery stenosis by FFR and RFR
6. 08:55 - 09:00
  
  Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty. The SirPAD randomized trial
7. 09:00 - 09:05
  
  Clinical usage of the GPX embolic device in peripheral applications
8. 09:05 - 09:10
  
  Treatment of the femoro-popliteal district with the innovative Exist NiTi stent (QMEDICS) type FLEX and PULL: The HORIZON clinical trial
9. 09:10 - 09:15
  
  Smart and sensing endovascular robot SENTANTE
10. 09:15 - 09:20
  
  CaveoVasc. protection system to reduce bleeding complications during catheter directed thrombolysis – results from the first in men study
11. 09:20 - 09:25
  
  Efficacy of fusion imaging in endovascular revascularisation of the femoral-popliteal artery
12. 09:25 - 09:30
  
  PRIZER: Multicentre study with RenzanTM stent for endovascular interventions in femoropopliteal area (NCT04546477)
13. 09:30 - 09:45
  
  Discussion and conclusion
9:00 - 9:40, Scientific Posters

Moderated poster round – Challenging cases: BTK, CLI, Femoral, PVD, SFA

Juror:

Luis Palena, Francesco Liistro
1. 09:00 - 09:05
  
  The long pathway to the successful endovascular treatment of critical lower limb ischemia in a young male patient with psoriasis – an unusual clinical case
2. 09:05 - 09:10
  
  Limb salvage after COVID-19 related extensive arterial thrombosis in an 81 years lady with critical limb ischemia: A case report
3. 09:10 - 09:15
  
  Bilateral acute thrombotic ischemia associated with COVID-19 infection rescued using a combination of treatment tools
4. 09:15 - 09:20
  
  Methicillin resistant Staphylococcus aureus infection in vascular surgery patients
5. 09:20 - 09:25
  
  Distal radial puncture for thrombectomy of the radial and brachial artery in a patient with acute upper limb ischemia
6. 09:25 - 09:30
  
  Complex recanalisation of common femoral artery, SFA and popliteal artery
7. 09:30 - 09:35
  
  Atherectomy with drug eluting balloon for common femoral artery occlusive disease: Early experience
8. 09:35 - 09:40
  
  Trans dorsalis pedis accesses for superficial femoral artery stunting is another alternative approach for bail-out cases
9:15 - 10:30, Main Arena 1

First time right! Optimizing acute to long-term outcomes in lower limb revascularisation

supported by Philips

Moderator:

Mark Portou, Michael Lichtenberg

Panel:

Konstantinos Stavroulakis, Ashish Patel, Marco Manzi
1. 09:15 - 09:22
  
  Accurate assessment – see better to treat better
2. 09:22 - 09:29
  
  Optimized vessel preparation – plaque disruption, ablation, and removal
3. 09:29 - 09:36
  
  Definitive therapy – the importance of focal dissection repair
4. 09:36 - 09:56
  
  Live case transmission from Münster
5. 09:56 - 10:30
  
  Discussion and conclusion
9:15 - 10:00, Main Arena 2

FOCUS SESSION: How should you approach patients with a vasculogenic erectile dysfunction?

supported by Concept Medical

Moderator:

Roxana Mehran

Panel:

Giuseppe Massimo Sangiorgi, Theodosios Bisdas, Federico Deho
1. 09:15 - 09:20
  
  Vasculogenic erectile dysfunction: We don’t ask, they don’t talk
2. 09:20 - 09:28
  
  What European guidelines recommends for ED treatment
3. 09:28 - 09:42
  
  Mechanical revascularization for patients with vasculogenic erecile dysfunction
4. 09:42 - 09:47
  
  Adjunctive therapies for erectile dysfunction
5. 09:47 - 10:00
  
  Discussion and conclusion
9:45 - 11:15, Speakers Corner

Latest clinical data and original research papers: PVD/Iliac/Carotid

Moderator:

Ralf Langhoff, Martin Werner
1. 09:45 - 09:50
  
  The impact of statin treatment intensity after endovascular revascularisation for lower extremity peripheral artery disease
2. 09:50 - 09:55
  
  Gender-driven underutilized guideline-recommended outpatient management of intermittent claudication and chronic limb threatening ischemia – a population-based study in Germany between 2009–2018
3. 09:55 - 10:00
  
  Clinical outcomes of endovascular procedure using VIABAHN. VBX covered stent in complex aortoiliac artery disease: Results from AVOCADO study
4. 10:00 - 10:05
  
  Pediatric vascular injuries management: Single center experience
5. 10:05 - 10:10
  
  Combined duplex guided angioplasty with contrast-free fluoroscopy for treatment of femoro-popliteal arterial lesions in patients with renal insufficiency. A multicenter experience
6. 10:10 - 10:15
  
  Role of ankle peak systolic velocity as a hemodynamic predictor following infra inguinal arterial angioplasty
7. 10:15 - 10:20
  
  Hybrid treatment of iliac segment occlusion in combination with lesions of the common femoral artery
8. 10:20 - 10:25
  
  Long-term outcomes of supra-inguinal arterial bypass
9. 10:25 - 10:30
  
  Surgical resection of paragangliomas is the only curative treatment: A series of 53 cases of single center experience in Arab Peninsula
10. 10:30 - 10:35
  
  Impact of shaggy aorta on intraoperative cerebral embolism during carotid artery stenting
11. 10:35 - 10:40
  
  Cost-effectiveness of ultrasound renal denervation in patients with resistant hypertension
12. 10:40 - 10:45
  
  Cone beam computed tomography image fusion in renal tumor ablation: Preliminary data
13. 10:45 - 10:50
  
  Imaging-guided percutaneous direct needle puncture of visceral pseudoaneurysms: Feasibility and outcomes
14. 10:50 - 10:55
  
  Endovascular treatment for visceral arteries occlusive disease
15. 10:55 - 11:15
  
  Discussion and conclusion
10:00 - 11:45, Main Arena 2

Endovascular procedures for the deep veins

Moderator:

Houman Jalaie, Thomas Zeller

Panel:

Marzia Lugli, Narayan Karunanithy
1. 10:00 - 10:27
  
  Live case transmission from Zurich
2. 10:27 - 10:34
  
  Armamentarium of imaging techniques for guiding interventions in the deep veins
3. 10:34 - 10:41
  
  A randomized controlled trial comparing venous stenting with conservative treatment in patients with deep venous obstruction (STEVECO)
4. 10:41 - 10:48
  
  Update on dedicated stents for the deep veins
5. 10:48 - 10:55
  
  Update on thrombectomy systems for the deep veins
6. 10:55 - 11:02
  
  The TOPOS study: 2-year clinical outcomes of a hybrid oblique nitinol stent for patients with postthrombotic syndrome and common iliac vein compression
7. 11:02 - 11:09
  
  Why do venous stents occlude? Factors that invluence outcomes after deep venous stenting
8. 11:09 - 11:16
  
  Venous stent complications: Fracture, migration, contralateral thrombosis, etc.
9. 11:16 - 11:36
  
  Live case transmission from Zurich
10. 11:36 - 11:45
  
  Discussion and conclusion
10:30 - 11:15, Main Arena 1

Real-world catheter-based reperfusion strategies for the treatment of acute DVT and PE

supported by Boston Scientific

Moderator:

Andrew Sharp

Panel:

Stefano Barco, Nils Kucher
1. 10:30 - 10:32
  
  Welcome and introduction
2. 10:32 - 10:44
  
  How I treat a patient presenting with iliofemoral DVT – rethro data on EKOS Angiojet
3. 10:44 - 10:56
  
  How I treat a patient presenting with pulmonary embolism – Zurich pathway
4. 10:56 - 11:08
  
  Present and future EKOS clinical data – KNOCOUT PE data and HiPeitho trial
5. 11:08 - 11:15
  
  Q&A, discussion, and conclusion
11:00 - 11:30, Scientific Posters

Moderated poster round – Challenging Cases: Venous, AV, Visceral

Juror:

Panagiotis Kitrou, Tobias Hirsch
1. 11:00 - 11:05
  
  Alternative surgical techniques to rescue arteriovenous accesses for hemodialysis
2. 11:05 - 11:10
  
  Endovascular recanalisation of failing arteriovenous fistula with complex anatomy
3. 11:10 - 11:15
  
  When Fasciotomy is needed in extensive left iliofemoral deep vein thrombosis – case report
4. 11:15 - 11:20
  
  Catheter directed-thrombectomy with the JETi8 in the treatment of acute superior vena cava syndrome, a case report
5. 11:20 - 11:25
  
  Endovenous microwave ablation of great saphenous vein in the treatment of acute superficial venous thrombosis: A case report
6. 11:25 - 11:30
  
  Saving a patient with massive bowel necrosis following undiagnosed acute mesentric ischemia: A case report
11:15 - 12:30, Main Arena 1

Endoluminal bypass for the treatment of complex lower limb disease

supported by W. L. Gore & Associates

Moderator:

Michel Reijnen

Panel:

Michele Piazza, Christian Habermann
1. 11:15 - 11:20
  
  Introduction from the moderator
2. 11:20 - 11:35
  
  Iliac: Your TASC II C&D patients – the value of covered stents in treating AIOD
3. 11:35 - 11:45
  
  Live case transmission from Leipzig
4. 11:45 - 12:00
  
  SFA: Strengthening clinical performance in your most challenging patients – the treatment options and the data by Michel Reijnen
5. 12:00 - 12:15
  
  SFA: Strengthening clinical performance in your most challenging patients –case presentation by Christian Habermann
6. 12:15 - 12:25
  
  Live case revisited
7. 12:25 - 12:30
  
  Q&A, discussion, and conclusion
11:15 - 12:30, Speakers Corner

Latest clinical data and original research papers: Femoropopliteal – Part I

Moderator:

Yann Gouëffic, Hans Krankenberg
1. 11:15 - 11:20
  
  Femoro-popliteal bypass vs. interwoven biomimetic nitinol stents in the prolonged occlusions of the femoro-popliteal segment: A propencity matched analysis
2. 11:20 - 11:25
  
  Results of hybrid revascularisation fasciotomy plus drug eluting stent of prolonged lesions of the femoral-popliteal segment
3. 11:25 - 11:30
  
  Endovascular recanalization with stenting vs. remote endarterectomy for the superficial femoral artery total occlusive lesions: A prospective randomized trial
4. 11:30 - 11:35
  
  Comparison of clinical outcome between low-dose and high-dose Paclitaxel drug-coated balloon in endovascular therapy for femoropopliteal lesion
5. 11:35 - 11:40
  
  Korean multicenter prospective registry of In.PACT drug-coated balloon for popliteal artery disease (K-POP study): Preliminary results
6. 11:40 - 11:45
  
  2-year results of the RANGER II SFA randomized trial
7. 11:45 - 11:50
  
  Intravascular lithotripsy for the treatment of calcified peripheral artery disease in patients on hemodialysis
8. 11:50 - 11:55
  
  MIMICS-3D: 3-year clinical outcomes for the BioMimics 3D stentin a real-world population
9. 11:55 - 12:00
  
  Mechanical atherothrombectomy reduces plaque burden and improves endothelial function in peripheral artery disease
10. 12:00 - 12:05
  
  NiTiDES™: Sirolimus Self-Exp DES technology and clinical study update
11. 12:05 - 12:10
  
  Cost of reintervention following femoropopliteal artery revascularisation with drug-eluting compared with bare metal stents among united states medicare beneficiaries
12. 12:10 - 12:15
  
  Validating the clinical utility of intravascular ultrasound guidance during lower-extremity peripheral vascular interventions using claims data in Japan from 2009–2020
13. 12:15 - 12:20
  
  Latest insights from the COMPARE study on low-dose versus high-dose PCB: 3 year results and TLR characteristics
14. 12:20 - 12:30
  
  Discussion and conclusion
11:45 - 12:30, Main Arena 2

Think venous: The way forward through a multidisciplinary approach with proven technologies

supported by BD

Moderator:

Stephen Black

Panel:

Romaric Loffroy, Michal-Goran Stanisic, Efthymios Avgerinos, Houman Jalaie, Oliver Schlager
1. 11:45 - 11:50
  
  Keeping the patient at the centre of this journey – a multidisciplinary approach
2. 11:50 - 11:58
  
  Recorded case presentation: How to avoid thrombolysis in iliofemoral DVT and the advantage of pure mechanical thrombectomy
3. 11:58 - 12:06
  
  Identifying the right patient for venous stenting: Who, when, and how?
4. 12:06 - 12:14
  
  Recorded case presentation: Attaining the maximal inflow in patients with extensive chronic venous obstruction
5. 12:14 - 12:20
  
  Antithrombotic treatment after venous stenting and an update of the ARIVA trial
6. 12:20 - 12:30
  
  Panel discussion
12:30 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: BTK controversies – how would you treat?

supported by Abbott Vascular

Moderator:

Koen Deloose

Panel:

Lieven Maene, Tobias Koppara
1. 12:30 - 12:33
  
  Opening/session objectives
2. 12:33 - 12:43
  
  Below-the-knee: Access and vessel preparation – how would you do it?
3. 12:43 - 12:48
  
  Discussion
4. 12:48 - 12:58
  
  Below-the-knee: How intravascular imaging could make a difference
5. 12:58 - 13:03
  
  Discussion
6. 13:03 - 13:13
  
  Below-the-knee: Optimal treatment now and in the future?
7. 13:13 - 13:15
  
  Discussion and conclusion
12:30 - 13:15, Main Arena 2

LUNCH SYMPOSIUM: Lifting the boundaries of VTE treatment with INARI lytic-free therapy solutions

supported by Inari Medical

Moderator:

Michael Lichtenberg

Panel:

Andrew Wigham, Rick de Graaf, David Dexter
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:45
  
  Expanding treatment options for sub-acute DVT with the Inari system
3. 12:45 - 12:55
  
  A new era in thrombus removal: ClotTriever as the first-choice device for DVT treatment
4. 12:55 - 13:05
  
  CLOUT registry: Putting sight on a treatment option for acute, sub-acute, and chronic DVT
5. 13:05 - 13:15
  
  Discussion and conclusion
12:30 - 13:15, Speakers Corner

LUNCH SYMPOSIUM: The CLI battle: new frontiers – guidelines and toolbox for your daily practice

sponsored by Cordis

Moderator:

Marco Manzi

Panel:

Erwin Blessing, Maria Antonella Ruffino
1. 12:30 - 12:32
  
  Introduction
2. 12:32 - 12:44
  
  Current state of CLI in Europe - Guidelines on diagnosing, treating, and patient selection
3. 12:44 - 12:56
  
  Tibio-pedal artery access – when and how to use it?
4. 12:56 - 13:08
  
  CLI strategies and case management
5. 13:08 - 13:15
  
  Q&A and take home message
13:00 - 13:45, Scientific Posters

Moderated poster round – Challenging cases: Carotid, Iliac, Renal

Juror:

Frans Moll, Peter Goverde
1. 13:00 - 13:05
  
  Limb salvage after complete cut of the brachial artery following combined cut arm and cut wrist injuries: A case report
2. 13:05 - 13:10
  
  Intravascular ultrasound as a useful tool in the misdiagnosis of carotid web and its management
3. 13:10 - 13:15
  
  Recurrent transient ischemic attack: An unusual cause and endovascular treatment
4. 13:15 - 13:20
  
  Traumatic brachial artery pseudoaneurysm
5. 13:20 - 13:25
  
  Sirolimus-eluting balloon PTA for in-stent restenosis of carotid artery stents – first in men results
6. 13:25 - 13:30
  
  Complex CERAB in fragile female patient
7. 13:30 - 13:35
  
  Spontaneous isolated common iliac artery dissection in young adult
8. 13:35 - 13:40
  
  The unusual acute limb ischemia, caused by impingement of external iliac artery by pelvic tumor
9. 13:40 - 13:45
  
  Endovascular treatment of the renal artery in a young kidney transplant patient with high risk of graft loss
13:30 - 14:45, Main Arena 1

SYMPOSIUM: Directional atherectomy plus drug-coated balloons to treat long, calcified femoropopliteal artery lesions: Current data and a live case

supported by Medtronic

Moderator:

Dierk Scheinert

Panel:

Thomas Zeller, Antonio Micari
1. 13:30 - 13:40
  
  IN.PACT Admiral DCB for the treatment of long/complex lesions
2. 13:40 - 13:50
  
  The REALITY study 12-month results
3. 13:50 - 14:40
  
  Live case transmission from Leipzig
4. 14:40 - 14:45
  
  Q&A, discussion, and conclusion
13:30 - 15:00, Main Arena 2

Acute venous thromboembolism

Moderator:

Oliver Schlager, Sigrid Nikol

Panel:

Robert Lookstein, Kenneth Rosenfield, Bruno Freitas, Houman Jalaie
1. 13:30 - 13:50
  
  Live case transmission from Zurich
2. 13:50 - 14:00
  
  Anticoagulation therapy and catheter-directed thrombolysis in patients with COVID-19 associated venous thromboembolism
3. 14:00 - 14:10
  
  Advanced treatment for intermediate- and high-risk PE – options, indications, and caveats
4. 14:10 - 14:20
  
  Clinical trial programs for intermediate and high risk PE patients
5. 14:20 - 14:30
  
  FlowTriever thrombectomy for intermediate risk PE patients – initial experience
6. 14:30 - 14:40
  
  FlowTriever thrombectomy for high risk PE patients – initial experience
7. 14:40 - 15:00
  
  Live case transmission from Zurich
13:30 - 14:45, Speakers Corner

Latest clinical data and original research papers: Femoropopliteal – Part II

Moderator:

Erwin Blessing, Eugenio Stabile
1. 13:30 - 13:35
  
  Application of the GoBack™ crossing catheter in endovascular revascularisation of chronic total occlusion in patients with chronic limb threatening ischemia
2. 13:35 - 13:40
  
  Circumferential micro-incision prior to PTA reduces extent & severity of dissections vs. PTA alone: A single center prospective data analysis
3. 13:40 - 13:45
  
  Auryon™ laser in peripheral arterial interventions: A single center experience (Auryon-SCE)
4. 13:45 - 13:50
  
  Mid-term outcomes of directional atherectomy in femoropopliteal artery disease
5. 13:50 - 13:55
  
  Usage of contemporary drug-eluting stent by japanese interventional radiologists for femoropopliteal in-stent restenosis lesions: COMBAT-ISR study
6. 13:55 - 14:00
  
  Intravascular lithotripsy in calcified peripheral lesions: The real-world single-center JEN-experience
7. 14:00 - 14:05
  
  Korean multicenter prospective registry of In.PACT drug-coated balloon for popliteal artery disease (K-POP study): Preliminary results
8. 14:05 - 14:10
  
  Primary patency rate of native vessel revascularisation after failed femoropopliteal bypass surgery
9. 14:10 - 14:15
  
  Jetstream atherectomy followed by Paclitaxel-coated balloons vs. balloon angioplasty followed by Paclitaxel-coated balloons: 12-month results of the prospective randomized JET-RANGER study
10. 14:15 - 14:20
  
  Revascularisation in acute ischemia in patients with SARS-CoV-2
11. 14:20 - 14:25
  
  Paclitaxel blood concentration after peripheral DCB PTA evaluated by HPLC (High Pressure Liquid Chromatography)
12. 14:25 - 14:30
  
  New safety and effectiveness data of Luminor DCB at 5-year: EFFPAC TRAIL
13. 14:30 - 14:35
  
  First experience with MagicTouch Angioplasty, Sirolimus coated balloon for peripheral vessels combined in various techniques of closed and open endovascular procedures in more than 80 cases
14. 14:35 - 14:45
  
  Discussion and conclusion
14:45 - 15:30, Main Arena 1

Low-profile access and new access routes for peripheral arterial procedures

Moderator:

Jos van den Berg

Panel:

Yann Gouëffic, Eugenio Stabile, Marcus Thieme, Lieven Maene, Luis Palena
1. 14:45 - 14:50
  
  The cost savings and avoided complications of low-profile 4F interventions
2. 14:50 - 15:25
  
  Live case transmission from Münster
3. 15:25 - 15:30
  
  Are we ready for a new approach to iliac lesions? Benefits and limitations to radial access for iliac stenting
14:45 - 16:00, Speakers Corner

Challenging cases and complications: PVD/Iliac/SFA/Visceral/Renal

Moderator:

Hans Krankenberg, Martin Werner
1. 14:45 - 14:50
  
  Antegrade and retrograde thrombectomy of an axillary-popliteal bypass using the Rotarex atherectomy catheter in a patient with acute limb ischemia
2. 14:50 - 14:55
  
  Intravascular (IVUS)-guided endovascular thrombectomy of aortic thrombosis in COVID-19 patient
3. 14:55 - 15:00
  
  The “needle bypass” technique: Percutaneous anatomical bypass with needle rendezvous for patients with peripheral arterial disease that have no other surgical options
4. 15:00 - 15:05
  
  An innovative technique for aorto-iliac revascularisation: MISC-AB – Mini-Invasive Sutureless and Clampless Aortic Bypass
5. 15:05 - 15:10
  
  Preservation of precious cross-over bypass graft despite acute COVID-19, GI bleeding and occlusion of all previous revascularisations: A description and audience query
6. 15:10 - 15:15
  
  A case of an aneurysm spurium of a side branch of the popliteal artery following a proximal fracture of the lower leg and treatment with an external fixator
7. 15:15 - 15:20
  
  A huge pseudoaneurysm in a 10 years child after missed iatrogenic injury of the popliteal artery with distal limb ischemia: A case report
8. 15:20 - 15:25
  
  The “needle re-entry” technique for infrainguinal arterial calcified occlusive lesions
9. 15:25 - 15:30
  
  Iatrogenic arteriovenous fistulas (AVF) after endovascular recanalisation and angioplasty of BTK arteries occlusions, leading to stealing of the BTK blood flow. Successful correction of stealing by DES stents
10. 15:30 - 15:35
  
  Staged treatment for pancreaticoduodenal artery aneurysm with celiac artery revascularisation: Case report and systematic review
11. 15:35 - 15:40
  
  Nutcracker syndrome: Intravascular ultrasound guided treatment
12. 15:40 - 15:45
  
  Goldblatt kidney – a stitch in time saves nine
13. 15:45 - 16:00
  
  Discussion and conclusion
15:00 - 15:30, Main Arena 2

Latest innovation from Penumbra: Computer-aided thrombus removal with Lightning® Intelligent Aspiration

supported by Penumbra

Moderator:

Martin Austermann

Panel:

Maria Antonella Ruffino, Nikolaos Tsilimparis
1. 15:00 - 15:10
  
  Early experience in the management of acute limb ischemia with Lightning®
2. 15:10 - 15:20
  
  How Lightning® has changed my clinical practice in acute limb ischemia
3. 15:20 - 15:30
  
  Discussion and conclusion
15:00 - 15:40, Scientific Posters

Moderated poster round – Original Research: BTK, Femoral, PVD, SFA

Juror:

Thomas Zeller, Francesco Liistro
1. 15:00 - 15:05
  
  Results of endovascular arterial treatment in flexion area
2. 15:05 - 15:10
  
  Percutaneous recanalisation of very long femoro-popliteal chronic total occlusions
3. 15:10 - 15:15
  
  Usefulness of vertical femoral artery puncture with antegrade approach in endovascular therapy
4. 15:15 - 15:20
  
  Dose management capabilities of digital variance angiography: 70% decrease of DSA-related radiation exposure in lower limb x-ray angiography
5. 15:20 - 15:25
  
  Diagnostic performance of digital variance angiography in reduced radiation lower limb examinations
6. 15:25 - 15:30
  
  The primary patency in endovascular treatment of femoropopliteal lesions with Eluvia Paclitaxel-Eluting stent: Single-centre experience
7. 15:30 - 15:35
  
  A new concept in vascular surgery: The percutaneous bypass (Percut Bypass)
8. 15:35 - 15:40
  
  Analysis of the safety and efficacy of the endovascular treatment for acute limb ischemia with percutaneous pharmacomechanical thrombectomy compared with catheter-directed thrombolysis
15:30 - 16:00, Main Arena 1

FOCUS SESSION: The emerging value of out-of-hospital sites of care

supported by Philips

Moderator:

Dierk Scheinert

Panel:

Foluso Fakorede, Janice Tsui, Ounali Jaffer
1. 15:30 - 15:40
  
  Lessons learned in providing out of hospital care in a remote, underserved region of Mississippi
2. 15:40 - 16:00
  
  Panel discussion
15:30 - 16:15, Main Arena 2

Interventional options for AV-access related problems

Moderator:

Tobias Steinke, Panagiotis Kitrou

Panel:

Jackie Ho, Robert Lookstein, Matteo Tozzi, Daniela Branzan, Narayan Karunanithy
1. 15:30 - 15:35
  
  Paclitaxel DCBs for dysfunctional AVF: The mechanism of action
2. 15:35 - 15:40
  
  The IN.PACT AV access study: Results through 36 months
3. 15:40 - 15:45
  
  The IN.PACT AV access study: Economic outcomes
4. 15:45 - 15:50
  
  Treating cephalic arch stenosis: Why, when, and how?
5. 15:50 - 15:55
  
  Stent-grafts for AV access revisions: New developments in innovation and evidence
6. 15:55 - 16:00
  
  Treating AVF lesions in the cephalic arch: What does the data tell us?
7. 16:00 - 16:05
  
  Endovascular treatment for dialysis access related Steal syndrome
8. 16:05 - 16:10
  
  Beyond PTA: How I incorporate devices like DCBs and stents for AV access maintenance
9. 16:10 - 16:15
  
  Discussion and conclusion
16:00 - 16:45, Main Arena 1

Save a limb to save a life – new horizons with Sirolimus eluting balloons in treating CLI patients – global experience

a case based discussion, supported by Medalliance

Moderator:

Michael Lichtenberg

Panel:

Bella Huasen, Tjun Tang, Luis Palena, Ehrin Armstrong
1. 16:00 - 16:10
  
  SELUTION SLR Sirolimus eluting balloon technology: Why does it matter to our patients?
2. 16:10 - 16:20
  
  Case 1: A CLI/BTK patient from Singapore – Asian experience
3. 16:20 - 16:30
  
  Case 2: A CLI/BTK patient from Italy – European experience
4. 16:30 - 16:40
  
  Next stop USA – latest update on the SELUTION4BTK IDE clinical trial
5. 16:40 - 16:45
  
  Discussion and conclusion
16:00 - 17:00, Speakers Corner

Challenging cases and complications: Carotid/Embolization

Moderator:

Piero Montorsi, Piotr Musialek
1. 16:00 - 16:05
  
  Brachial artery entrapment after supracondylar humeral fracture – a case report
2. 16:05 - 16:10
  
  Left subclavian aneurysm in Ehler Danlos patient treated with coned covered stent Gore VBX+VHB
3. 16:10 - 16:15
  
  4 vessel extracranial fibromuscular dysplasia requires 3D modelling
4. 16:15 - 16:20
  
  Combined endovascular repair of a ruptured left subclavian artery aneurysm – a case report and literature review
5. 16:20 - 16:25
  
  Two level angioplasty of critically stenosed left carotid artery with proximal neuroprotection and use of intravascular lithotripsy catheter (IVL)
6. 16:25 - 16:30
  
  TCAR and intravascular lithotripsy: An effective combination treatment for carotid artery stenosis
7. 16:30 - 16:35
  
  A rare case of post-traumatic high-flow priapism requiring endovascular salvage with bilateral superselective microcoil embolization
8. 16:35 - 16:40
  
  Pain in the neck: Urgent microcoil embolization of a ruptured thyrocervical trunk
9. 16:40 - 17:00
  
  Discussion and conclusion
16:15 - 17:00, Main Arena 2

SYMPOSIUM: Fistula creation and maintenance for ESKD patients: Applying long-term data to the care continuum

supported by Medtronic

Moderator:

Alexandros Mallios

Panel:

Ounali Jaffer, Fabrizio Fanelli
1. 16:15 - 16:18
  
  Welcome
2. 16:18 - 16:28
  
  Implications of long-term data for fistula maintenance
3. 16:28 - 16:38
  
  Algorithm for fistula creation: The Paris experience
4. 16:38 - 16:48
  
  Experiences as a new EndoAVF user
5. 16:48 - 16:58
  
  Panel discussion
6. 16:58 - 17:00
  
  Closing
16:45 - 18:00, Main Arena 1

The challenge of calcification in BTK interventions

Moderator:

Luis Palena, Thomas Zeller

Panel:

Sean Lyden, Miguel Montero-Baker, Ehrin Armstrong, Ralf Langhoff, Roberto Ferraresi
1. 16:45 - 16:50
  
  Calcium definitions in endovascular clinical trials: Is the struggle real?
2. 16:50 - 16:55
  
  Small artery disease and medial artery calcification: The silent killer of the leg
3. 16:55 - 17:00
  
  Ultrasound based calcium score for the identification of no option CLTI
4. 17:00 - 17:20
  
  Live case transmission from Leipzig
5. 17:20 - 17:25
  
  FIRST TIME DATA RELEASE: Prestige pilot study: IVUS guided Phoenix atherectomy and Stellarex DCB angioplasty in BTK interventions. 12-month final data presentation
6. 17:25 - 17:30
  
  LIBERTY real world evidence on CLI and diabetic patients
7. 17:30 - 17:35
  
  OCT guided atherectomy for BTK-disease, clinical outcome in a prospective analysed patient cohort
8. 17:35 - 17:40
  
  Initial 50 patient experience with the Phoenix 1.5 mm atherectomy system
9. 17:40 - 17:45
  
  Orbital atherectomy in the foot arteries: Clinical results
10. 17:45 - 17:50
  
  What is the role of intravascular lithotripsy for infrapopliteal vessels?
11. 17:50 - 18:00
  
  Discussion and conclusion
17:00 - 18:00, Main Arena 2

Interventional oncology: Hepatic interventions II

Moderator:

Ulf Teichgräber

Panel:

Frank Wacker, Daniel Nißler
1. 17:00 - 17:10
  
  Hepatic wedge pressure measurement – indications, materials, and technique
2. 17:10 - 17:20
  
  TIPSS – register study DeGIR
3. 17:20 - 17:40
  
  Live case transmission from Jena
4. 17:40 - 17:50
  
  PVR-TIPSS-translienal portal vein recanalisation –indications, technique, results
5. 17:50 - 18:00
  
  Recorded case presentation: PVR-TIPSS-translienal portal vein recanalisation – indications, technique, results

Conference day 3

Wednesday, June 8th 2022

8:00 - 9:00, Main Arena 1

CONNECT THE WORLD SESSION in collaboration with CEC: The state of art in SFA treatment insights from global experts

partially supported by Medtronic

Moderator:

Dierk Scheinert, Andrej Schmidt

Co-Moderator:

Zhong Chen, Weiguo Fu, Wei Guo
1. 08:00 - 08:05
  
  Opening
2. 08:05 - 08:35
  
  Live case transmission from Chengdu
3. 08:35 - 08:40
  
  How to optimize vessel preparation with the chocolate balloon
4. 08:40 - 08:45
  
  Complex SFA disease: Tackling calcium with Directional Atherectomy
5. 08:45 - 08:50
  
  IN.PACT Admiral DCB - Long term outcomes from the IN.PACT Admiral clinical program
6. 08:50 - 08:55
  
  How do drug-coated balloons perform in patients with critical limb ischemia? 5-year outcomes from the IN.PACT global study
7. 08:55 - 09:00
  
  Discussion and conclusion
8:00 - 9:00, Main Arena 2

Endovascular treatment of aortoiliac aneurysms: Techniques and results

Moderator:

Giovanni Torsello, Martin Malina

Panel:

Spiridon Botsios, Daniela Branzan, Konstantinos Donas, Hans Henning Eckstein
1. 08:00 - 08:05
  
  Mechanical characterisation of abdominal aortic aneurysm, using 4D ultrasound
2. 08:05 - 08:10
  
  How sac regression at 1 year affects all-cause mortality through 8 years: Key insights from the ENGAGE registry
3. 08:10 - 08:15
  
  FORS technology: Branched clinical usage, learnings and future perspectives
4. 08:15 - 08:40
  
  Live case transmission from Münster
5. 08:40 - 08:45
  
  5-year follow up data of an iliac branch device
6. 08:45 - 08:50
  
  Preservation of the internal iliac artery: The GALIBER study
7. 08:50 - 08:55
  
  Endovascular treatment of challenging iliac with co-existing internal iliac aneurysms: A new European registry
8. 08:55 - 09:00
  
  Anterior vs. posterior divisional branches: Where to land better in case of internal iliac artery aneurysms – the ROYAL-registry
8:30 - 9:45, Speakers Corner

Latest results from clinical trials and innovations

Moderator:

Francesco Liistro, Jos van den Berg
1. 08:30 - 08:35
  
  Natural progression of high-risk chronic limb-threatening ischemia: The CLariTI study
2. 08:35 - 08:40
  
  Results of the Prelude BTK study: Novel serration angioplasty balloon for the below-the-knee arteries
3. 08:40 - 08:45
  
  Update on the DEEPER LIMUS trial: The temporary Spur stent system in conjunction with a Sirolimus-coated balloon
4. 08:45 - 08:50
  
  The novel temporary Spur stent system used in conjunction with a commercially available, Paclitaxel-coated balloon: 6-months results of the DEEPER OUS trial – Arnsberg experience
5. 08:50 - 08:55
  
  Clinical risk associated with contrast angiography in metformin treated diabetes patients
6. 08:55 - 09:00
  
  Balloon assisted retrograde puncture of distal vessels in poor candidates for a conventional transpedal approach
7. 09:00 - 09:05
  
  Totally percutaneous arterialization of the foot trough the superficial dorsal venous system – SuperSaVe-technique
8. 09:05 - 09:10
  
  The Limus-Coated temporary Spur stent system: DEEPER drug therapy for infrapopliteal disease
9. 09:10 - 09:15
  
  Real-world performance of Novel Shock Wave wire in complex CTO lesions
10. 09:15 - 09:20
  
  The needle rendezvous technique: The novel guidewire externalization technique using a needle without inserting microcatheter
11. 09:20 - 09:25
  
  Multi-site tibial intervention procedure using XO cross microcatheters in triaxial support configuration including wireless microcatheter navigation
12. 09:25 - 09:30
  
  MOTIV bioresorbable BTK scaffold pilot study: Preliminary results through 6 months
13. 09:30 - 09:45
  
  Discussion and conclusion
9:00 - 9:30, Main Arena 1

ASK THE EXPERTS: Our personal tips and tricks with the interwoven nitinol stent

supported by Abbott Vascular

Moderator:

Ralf Langhoff, August Ysa, Lieven Maene
1. Panel discussion
9:00 - 10:15, Main Arena 2

Aortic solutions engineerd to last

supported by W. L. Gore & Associates

Moderator:

Marc van Sambeek

Panel:

Dittmar Böckler, Michele Antonello, Hence Verhagen, Colin Bicknell
1. 09:00 - 09:02
  
  Introduction from the moderator
2. 09:02 - 09:17
  
  Long-term follow up demonstrates durable TEVAR outcomes: A case discussion
3. 09:17 - 09:37
  
  Recorded case presentation: TEVAR
4. 09:37 - 09:52
  
  Long-term follow up demonstrates durable EVAR outcomes: A case discussion
5. 09:52 - 10:12
  
  Recorded case presentation: EVAR
6. 10:12 - 10:15
  
  Q&A, discussion, and conclusion
9:00 - 9:45, Scientific Posters

Moderated poster round – Original Research: EVAR

Juror:

Peter Goverde, Vicente Riambau
1. 09:00 - 09:05
  
  Outcomes of endovascular aneurysm repair using the Alto aortic stent graft at a major UK vascular centre
2. 09:05 - 09:10
  
  Iliac bifurcation reconstruction as completion in TAAAs endovascular treatment using Endologix AFX
3. 09:10 - 09:15
  
  Radiation doses during EVAR: The transition to a hybrid room
4. 09:15 - 09:20
  
  Monocentric retrospective study about median term remodeling of visceral aortic segment in complicated panaortic dissections treated with hybrid delayed procedure (TEVAR and infrarenal fenestration)
5. 09:20 - 09:25
  
  Early single-site experience with the new low profile MINOS Abdominal Stent-Graft System in patients with difficult aortoiliac anatomy
6. 09:25 - 09:30
  
  Fixing bridge technique combining distal covered self-expandable with proximal balloon expandable stent-graft in case of branched endografting
7. 09:30 - 09:35
  
  Off-the-shelf stent grafts implantations as the solution for treatment of some aorta and iliac artery aneurysms
8. 09:35 - 09:40
  
  Mid term and long term results of covering entry tears in Type B aortic dissections
9. 09:40 - 09:45
  
  Shortest apposition length at the first postoperative computed tomography angiography identifies patients at risk for developing a late Type Ia endoleak after endovascular aneurysm repair
9:30 - 10:15, Main Arena 1

Advanced techniques for challenging lesions

Moderator:

Dierk Scheinert

Panel:

Sabine Steiner, Edward Choke, Uei Pua
1. Live case transmission from Leipzig
2. Peripheral arterial vessel prepping with intravascular ultrasound and atherectomy – an interventionalist’s perspective
3. What does it take to optimise treatment of complex SFA lesions: Update on the BEST SFA trial
4. Outcomes of the covered self-expandable stents for the treatment of critical limb ischemia patients
9:45 - 11:00, Speakers Corner

Latest clinical data and original research papers: Interventions in CLTI – Part I

Moderator:

Luis Palena, Katja Mühlberg
1. 09:45 - 09:50
  
  Retrograde tibial access for revascularisation of long chronic total occlusion in patients with chronic limb threatening ischemia
2. 09:50 - 09:55
  
  Comparative study between negative pressure wound therapy and standard moist wound dressing
3. 09:55 - 10:00
  
  New strategy for reducing adverse cardiac events and improving survival of patients with chronic limb-threatening ischaemia
4. 10:00 - 10:05
  
  Factors predicting adverse outcomes for patients with chronic limb threatening ischaemia and infra-popliteal disease
5. 10:05 - 10:10
  
  Management of Buerger's disease in endovascular era
6. 10:10 - 10:15
  
  Standard balloon angioplasty vs. Serranator serration balloon angioplasty for the treatment of below-the-knee artery occlusive disease: A sub-analysis from the Vascular Center in Graz/Austria in the PRELUDE-BTK prospective study
7. 10:15 - 10:20
  
  Interim analysis results of PiPeR-registry prospective monocentric study on totally percutaneous foot veins arterialization
8. 10:20 - 10:25
  
  Revascularisation of target artery path is a substantial way for salvage of critical limb ischemia
9. 10:25 - 10:30
  
  Toe blood flow pattern just after pedal arch angioplasty and foot prognosis in the CLTI patients
10. 10:30 - 10:35
  
  Twelve months clinical outcomes of percutaneous deep venous arterialization with an alternative techniques and ordinary endovascular therapy devices for patients with chronic limb threatening ischemia: From the result of DEPARTURE Japan study
11. 10:35 - 10:40
  
  The cost effectiveness of deep vein arterialization
12. 10:40 - 10:45
  
  4-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease
13. 10:45 - 10:50
  
  Cre8™ BTK clinical results in below the knee complex patients
14. 10:50 - 11:00
  
  Discussion and conclusion
10:15 - 11:00, Main Arena 1

SYMPOSIUM: IVL – consistently tackling severe calcium

supported by Shockwave

Moderator:

Konstantinos Stavroulakis

Panel:

Raphael Coscas, Narayanan Thulasidasan, Michel Bosiers
1. 10:15 - 10:25
  
  Embracing the challenges created by severe calcification
2. 10:25 - 10:35
  
  Simplicity and reliability: Consistent strategy produces predicable outcomes across multiple vessel beds
3. 10:35 - 10:45
  
  Reducing the risks spawned by calcium in CLTI patients
4. 10:45 - 10:55
  
  A paradigm shift in managing hostile access and facilitating endograft delivery
5. 10:55 - 11:00
  
  Q&A, discussion, and conclusion
10:15 - 11:15, Main Arena 2

The challenging infrarenal neck: Technical solutions and insights

Moderator:

Hence Verhagen, Vicente Riambau

Panel:

Stefano Fazzini, Jean-Paul de Vries, Giovanni Torsello, Jorge Fernández Noya
1. 10:15 - 10:20
  
  Results from Zephyr study
2. 10:20 - 10:25
  
  Clinical update and lessons learned when treating challenging necks: Outcomes of the EXCeL registry
3. 10:25 - 10:30
  
  AAA sac regression after 5 years: Insights from the GREAT registry
4. 10:30 - 10:35
  
  FIRST TIME DATA RELEASE: Renal function after stentgraft treatment of abdominal aneurysm: the RENOFIX, a randomized clinical study
5. 10:35 - 10:40
  
  ADVANCE: A novel RCT comparing sac dynamics in Medtronic and Gore EVAR devices
6. 10:40 - 10:45
  
  Proximal aortic neck angulation and AAA outcomes: Learnings and considerations
7. 10:45 - 10:50
  
  A new era for ChEVAR: How the PROTAGORAS 2.0 study can predict sizing and planning optimization
8. 10:50 - 10:55
  
  ChEVAR: A true success story … if you do it right
9. 10:55 - 11:00
  
  Stabilizing high-risk seal zones: Mid-term EndoAnchor experience
10. 11:00 - 11:05
  
  ESAR provides long-term durability in challenging proximal necks: 5-year results from the global ANCHOR study
11. 11:05 - 11:10
  
  ESAR and FEVAR: How can evidence support tailored treatment of hostile neck AAA’s
12. 11:10 - 11:15
  
  Discussion and conclusion
11:00 - 11:45, Main Arena 1

Latest techniques for carotid revascularisation

Moderator:

Dierk Scheinert

Panel:

Piotr Musialek, Matteo Stefanini, Ralf Langhoff
1. 11:00 - 11:35
  
  Live case transmission from Leipzig
2. Micronet-covered stent in stroke prevention and treatment: New evidence
3. Mechanical properties and vessel adaptability of carotid stents: Could these change the procedural outcomes?
11:00 - 12:30, Speakers Corner

Latest clinical data and original research papers: AV access and venous

Moderator:

Houman Jalaie, Stephen Black
1. 11:00 - 11:05
  
  Outcome of angioplasty of occluded arteriovenous fistula for hemodialysis: Single centre experience
2. 11:05 - 11:10
  
  The significant related factors and 24-month intervention outcomes in Type-1 and non-Type 1 thoracic central vein obstruction in hemodialysis patients
3. 11:10 - 11:15
  
  XperCT facilitates sharp recanalization for the treatment of chronic thoracic venous occlusive disease in hemodialysis patients
4. 11:15 - 11:20
  
  Timing RSVP (Reperfusion symptoms to vein patency) in lower limbs large veins
5. 11:20 - 11:25
  
  AngioJet catheter directed thrombolysis for massive and submassive PE
6. 11:25 - 11:30
  
  Clot burden reduction after aspiration thrombectomy in main vs. branch pulmonary artery emboli: A subgroup analysis of the EXTRACT-PE trial
7. 11:30 - 11:35
  
  McCleery’s syndrome the overlooked cause of swollen upper limb, completion venoplasty is the key word for successful surgical decompression
8. 11:35 - 11:40
  
  Safety and efficacy of Endovenous Laser ablation (EVLA) using 1940nm and radial emitting fiber – 3-year results of a prospective, non-randomized study and comparison with 1470nm
9. 11:40 - 11:45
  
  Radiofrequency ablation for markedly incompetent perforators vs. compression therapy in the management of post-phelebtic venous ulcers: A randomized controlled trial
10. 11:45 - 11:50
  
  Transcatheter embolo-sclerotherapy of high flow arteriovenous malformations
11. 11:50 - 11:55
  
  Clinical update on a novel venous stent
12. 11:55 - 12:30
  
  Discussion and conclusion
11:00 - 12:00, Scientific Posters

Moderated poster round – Challenging cases: EVAR (part I)

Juror:

Reza Ghotbi, Hans Henning Eckstein
1. 11:00 - 11:05
  
  Combining stent-graft and VSD occluder to treat a challenging chronic Type B dissection
2. 11:05 - 11:10
  
  Role of Transoesophageal Echo in thoracic aneurysms with difficult cannulation of the true lumen
3. 11:10 - 11:15
  
  Complex multistage treatment of chronic Type B dissection: A case of LSA revascularisation with a fenestrated thoracic endograft
4. 11:15 - 11:20
  
  Acute aortic dissection with visceral malperfusion
5. 11:20 - 11:25
  
  Aortoesophageal fistula after aortic coarctation surgery, based on a real case
6. 11:25 - 11:30
  
  EVAR in ruptured aneurysm of the abdominal aorta with aortocaval fistula, long term result
7. 11:30 - 11:35
  
  Our experience with the use of endograft AFX2-VELA ENDOLOGIX in patients with aneurysmatic and/or ischemic pathology of the aorto-iliac sector
8. 11:35 - 11:40
  
  Endoleak Type 2: A plague following EVAR
9. 11:40 - 11:45
  
  Endovascular management of middle aortic syndrome in a chimney technique
10. 11:45 - 11:50
  
  Hybrid staged approach for treatment of complicated persistent sciatic artery aneurysm
11. 11:50 - 11:55
  
  Ortner's syndrome as the first symptom of thoracic aortic aneurysm, with coexisting subrenal abdominal aortic aneurysm and critical stenosis of the left internal carotid artery – case study
12. 11:55 - 12:00
  
  Multiple endovascular treatments for Type B aortic dissections (TBAD)
11:15 - 12:30, Main Arena 2

Zenith® t-Branch® a well-established choice to treat TAAAs

supported by COOK Medical

Moderator:

Tim Resch

Panel:

Alexander Zimmermann, Tilo Kölbel
1. 11:15 - 11:20
  
  Welcome from the moderator
2. 11:20 - 11:30
  
  Technical features carry technical success
3. 11:30 - 12:00
  
  Live case transmission from Hamburg
4. 12:00 - 12:10
  
  Standardizing complex procedures to optimize outcomes
5. 12:10 - 12:15
  
  Live case transmission from Hamburg
6. 12:15 - 12:30
  
  Q&A, discussion, and conclusion
11:45 - 12:30, Main Arena 1

Standing on evidence in SFA intervention

supported by Boston Scientific

Moderator:

Marianne Brodmann, Antonio Micari

Panel:

Sabine Steiner, Yann Gouëffic, Giovanni Torsello
1. 11:45 - 11:48
  
  Introduction: The evolution of clinical trials in SFA
2. 11:48 - 11:54
  
  FLASH PRESENTATION: Highlights and insights of DCB level 1 evidence
3. 11:54 - 12:00
  
  FLASH PRESENTATION: Highlights and insights of DES level 1 evidence
4. 12:00 - 12:06
  
  FLASH PRESENTATION: Highlights and insights of real world evidence
5. 12:06 - 12:27
  
  Panel discussion and audience interaction – Why evidence generation matters – What does this mean for our SFA treatment algorithm? – What does this mean for our patients? – What does this mean for our hospital system?
6. 12:27 - 12:30
  
  Conclusion and close
12:30 - 13:15, Main Arena 1

LUNCH SYMPOSIUM: The Alvimedica drug approach to the treatment of lower limb lesions

supported by Alvimedica

Moderator:

Ralf Langhoff

Panel:

Andrea Kahlberg, Stefan Müller-Hülsbeck, Marco Manzi, Marc Sirvent
1. 12:30 - 12:32
  
  Introduction and objectives
2. 12:32 - 12:39
  
  Amphilimus™: not only a pure drug option
3. 12:39 - 12:46
  
  Focus on SFA: What we know and what we don’t know about the use of Sirolimus
4. 12:46 - 12:53
  
  Focus on SFA: The NiTiDES™ solution
5. 12:53 - 13:00
  
  Focus on BTK: DES role in the treatment of the lower limb lesions
6. 13:00 - 13:07
  
  Focus on BTK: My personal experience with Cre8™ BTK
7. 13:07 - 13:13
  
  Discussion
8. 13:13 - 13:15
  
  Take-home messages and closure
12:30 - 13:15, Main Arena 2

LUNCH SYMPOSIUM: From data to everyday practice with Advanta V12: Trusted on table, reliable over time

supported by Getinge

Moderator:

Tilo Kölbel

Panel:

Andrej Schmidt, Jean-Paul de Vries, Lorenzo Patrone
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:43
  
  How to become an expert in complex AIOD treatment
3. 12:43 - 12:51
  
  Durability of Advanta V12 as a renal stent in complex aortic cases
4. 12:51 - 12:59
  
  A stent that you can count on at 5 years and beyond: Physician’s and patient’s experience
5. 12:59 - 13:15
  
  Discussion and conclusion
12:30 - 13:00, Speakers Corner

ASK THE EXPERTS: Optimal vessel closure with new generation suture mediated vessel closure device

supported by Abbott Vascular

Moderator:

Christian Erbel, Wouter Lansink
1. Panel discussion
13:30 - 14:45, Main Arena 1

SYMPOSIUM: Every patient journey deserves innovative PAD solutions: Access, restore, sustain

supported by BD

Moderator:

Koen Deloose

Panel:

Theodosios Bisdas, Bruno Migliara
1. 13:30 - 13:55
  
  Live case transmission from Zurich
2. 13:55 - 14:08
  
  Challenging patient journey chapter II – complex femeropopliteal CTO
3. 14:08 - 14:20
  
  Rotational mechanical atherothrombectomy in EVAR limbs – preliminary data
4. 14:20 - 14:35
  
  Challenging patient journey chapter III – complex iliac lesion management
5. 14:35 - 14:45
  
  Panel discussion
13:30 - 14:15, Main Arena 2

Tailoring complex endovascular repair with off-the-shelf solutions

supported by Medtronic

Moderator:

Vicente Riambau

Panel:

Konstantinos Donas, Andrés Reyes Valdivia, Jean-Paul de Vries
1. 13:30 - 13:33
  
  Welcome and introduction
2. 13:33 - 13:41
  
  Addressing the unmet needs of challenging neck anatomy patients
3. 13:41 - 13:49
  
  On-label ChEVAR: Why optimal device combination and standardized procedure yields durable results
4. 13:49 - 13:57
  
  The unique benefits of EndoAnchors in hostile proximal necks
5. 13:57 - 14:12
  
  Discussion
6. 14:12 - 14:15
  
  Closing remarks
13:30 - 14:45, Speakers Corner

Latest clinical data and original research papers: Interventions in CLTI – Part II

Moderator:

Marianne Brodmann, Marcus Thieme
1. 13:30 - 13:35
  
  Peroneal angioplasty for limb salvage in patient with critical limb ischemia, a case presentation
2. 13:35 - 13:40
  
  Utility of Sirolimus drug eluting balloons in the treatment of complex infra-inguinal atherosclerotic disease in patients with chronic limb threatening Ischemia – 6 months results from the PRISTINE registry
3. 13:40 - 13:45
  
  Results of CLI of the multicentric registry of lower limbs angioplasty in Argentina
4. 13:45 - 13:50
  
  Intraoperative tissue perfusion evaluation using near infrared spectroscopy during below-the-knee arteries revascularisation
5. 13:50 - 13:55
  
  Mid-term results of lytic therapy in vasculitic patients with acute ischemia
6. 13:55 - 14:00
  
  The catastrophic impact of COVID-19 infection in patients with chronic limb threatening ischaemia
7. 14:00 - 14:05
  
  Endovascular treatment in patients with thromboangiitis obliterans and chronic limb ischemia – systematic review and meta-analysis
8. 14:05 - 14:10
  
  Adipose-derived stem cells in patients with venous ulcers: A systematic review
9. 14:10 - 14:15
  
  Risk factors for early failure of transmetatarsal amputation performed in association to revascularisation of advanced chronic limb threatening ischemia
10. 14:15 - 14:20
  
  The role of targeted infra-popliteal endovascular angioplasty to treat diabetic foot ulcers using the angiosome model: A systematic review
11. 14:20 - 14:25
  
  WIfI classification vs. angiosome concept: A change in the infrapopliteal angioplasties paradigm
12. 14:25 - 14:45
  
  Discussion and conclusion
14:15 - 15:30, Main Arena 2

Latest solutions for endovascular thoracoabdominal aortic repair

supported by Artivion

Moderator:

Tim Resch

Panel:

Vladimir Makaloski, Sébastien Déglise, Said Abisi
1. 14:15 - 14:23
  
  Inner branches in dissections
2. 14:23 - 15:06
  
  Live case transmission from Leipzig
3. 15:06 - 15:14
  
  Technical learnings from Enside procedures
4. 15:14 - 15:22
  
  iBEVAR clinical experience
5. 15:22 - 15:30
  
  The role of 4D flow MRI in the use of inner branched TAAA devices: Reality or science fiction?
14:45 - 16:00, Main Arena 1

SYMPOSIUM: Sirolimus coated balloon: The future of peripheral intervention

supported by Concept Medical

Moderator:

Dierk Scheinert

Panel:

Aloke Finn, Edward Choke, Ulf Teichgräber, Francesco Liistro, Sahil Parikh, Stefano Barco
1. 14:45 - 14:52
  
  Is Sirolimus is a better option for PAD treatment
2. 14:52 - 15:07
  
  XTOSI 2 year results and updates on FUTURE BTK & SFA
3. 15:07 - 15:22
  
  Case from SIRONA RCT and presentation on LIMES study design
4. 15:22 - 15:35
  
  DEBATE BTK duell study design and case presentation with FU
5. 15:35 - 15:50
  
  The SirPAD randomized trial at half of target enrolment: Study update and exemplary case treated with sirolimus-coated balloon
6. 15:50 - 16:00
  
  Discussion and conclusion
14:45 - 16:00, Speakers Corner

Challenging cases and complications: AV access and venous

Moderator:

Panagiotis Kitrou, Ounali Jaffer
1. 14:45 - 14:50
  
  Massive hemothorax after sharp transeptal needle recanalisation of chronic right brachiocephalic venous occlusion with successful endovascular correction
2. 14:50 - 14:55
  
  Migration of stent placed in the left pulmonary vein into the iliac bifurcation
3. 14:55 - 15:00
  
  The outside-in double snare technique to treat long central venous occlusion
4. 15:00 - 15:05
  
  Nutcracker syndrome and management of co-existing of May-Thurner, median arcuate ligament, superior mesenteric artery, and/or pelvic congestion syndromes: A single-center experience of 26 patients
5. 15:05 - 15:10
  
  Catheter-directed thrombolysis and covered stent in a case of complete superior vena cava and brachiocephalic veins obstruction after cardiac transplantation for a rare heart defect
6. 15:10 - 15:15
  
  Great veins program: Do we have everything it takes?
7. 15:15 - 15:20
  
  Percutaneous thrombectomy of supra-inferior vena cava filter thrombosis
8. 15:20 - 15:25
  
  Dual pathway through femoral vein and urinary catheter for endovascular treatment of internal iliac vein injury
9. 15:25 - 15:30
  
  Inferior vena cava filter thrombosis: 10 years experience
10. 15:30 - 15:35
  
  Inferior vena cava tear
11. 15:35 - 15:40
  
  Endovascular retrieval of cement intracaval and in the common iliac vein: A fishing net technique
12. 15:40 - 15:45
  
  Epithelioid hemangioma of inferior vena cava: Initial catheter directed thrombolysis unmask the diagnosis
13. 15:45 - 15:50
  
  Bilateral iliac veins and vena cava obstruction treated with unilateral endovenous recanalisation and cross-femoral venous bypass using dilated superficial epigastric veins
14. 15:50 - 16:00
  
  Discussion and conclusion
15:00 - 15:50, Scientific Posters

Moderated poster round – Challenging cases: EVAR (part II)

Juror:

Spiridon Botsios, Martin Malina
1. 15:00 - 15:05
  
  Aortic intramural hematoma due to intercostal artery aneurysms
2. 15:05 - 15:10
  
  Stroke, spinal cord ischemia and upper limb ischemia in patients undergoing TEVAR with coverage of the left subclavian artery: A case series study
3. 15:10 - 15:15
  
  Descending thoaracic aorta TEVAR stent migration
4. 15:15 - 15:20
  
  A challenged endovascular treatment of bilateral internal iliac aneurysms combined with TAAA, using an off-the-shelf solution
5. 15:20 - 15:25
  
  Type II endoleak management after EVAR in AAAr with retroaortic left renal vein fistula
6. 15:25 - 15:30
  
  Inferior mesenteric artery salvage extra-fenestration in complex case of chronic Type B dissection treatment: Is the intraoperative risk worth taking?
7. 15:30 - 15:35
  
  An unusual 6 Fr approach of recurrent disease of a focal iliac aneurysm, preserving hypogastic artery
8. 15:35 - 15:40
  
  Two-stage TEVAR and BEVAR in symptomatic Type B dissection
9. 15:40 - 15:45
  
  Treatment of Type III endoleak after branched endovascular aneurysm repair
10. 15:45 - 15:50
  
  Single-step hybrid surgical treatment of posttraumatic aneurism of the thoracic aorta
15:30 - 16:15, Main Arena 2

Addressing abdominal complexities with custom solutions

supported by Terumo Aortic

Moderator:

Piotr Szopinski

Panel:

Kak Khee Yeung, Jürgen Falkensammer
1. 15:30 - 15:35
  
  Introduction
2. 15:35 - 15:45
  
  Next generation lower profile fenestrated device graft – initial feedback
3. 15:45 - 15:55
  
  How to cover the uncoverable with fenestrated iliac leg solution
4. 15:55 - 16:05
  
  Overcoming challenging anatomy with ring stent and unsupported fenestrated graft
5. 16:05 - 16:15
  
  Discussion and conclusion
16:00 - 16:25, Main Arena 1

VIVA@LINC – CLTI from challenges to milestones and what is next? – Part I: Big picture trends in CLTI

Moderator:

Peter Schneider, Marianne Brodmann

Panel:

Joshua Beckman, Tony Das, Raghu Kolluri, Roberto Ferraresi, Ralf Langhoff
1. Announcement Vascular Carreer Award
2. 16:00 - 16:05
  
  The cost of CLTI: How many amputations occur each year and what is the cost to the patient and society?
3. 16:05 - 16:10
  
  What is new in imaging, functional assessment, and perfusion monitoring?
4. 16:10 - 16:15
  
  Emerging trends: Models for team care, standardizing wound management, and best practices for long-term care
5. 16:15 - 16:25
  
  Discussion
16:00 - 17:00, Speakers Corner

Challenging cases and complications: EVAR – Part I

Moderator:

Maria Antonella Ruffino, Reza Ghotbi
1. 16:00 - 16:05
  
  A hybrid SMA debranching and periscope-EVAR for ruptured infected abdominal aortic aneurysm involving the visceral vessels
2. 16:05 - 16:10
  
  9 aneurysms : 1 patient
3. 16:10 - 16:15
  
  Infected EVAR & TEVAR after endovascular repair of impending rupture TAAA: The good, the bad and the ugly
4. 16:15 - 16:20
  
  How to do it: Chimney endovascular aneurysm repair (ChEVAR) of an abdominal aortic aneurysm associated with crossed fused renal ectopia
5. 16:20 - 16:25
  
  Endovascular repair of complex aortic aneurysms using physician-modified stent-graft with inner branches
6. 16:25 - 16:30
  
  Challenges and considerations associated with transsternal Zone 0 hybrid arch repair: Report of 2 cases
7. 16:30 - 16:35
  
  Emergency treatment of a symptomatic juxtarenal AAA after EVAR migration
8. 16:35 - 16:40
  
  Embolization of gutter-related Type Ia endoleak after chimney TEVAR via non-thrombosed vascular plug at left subclavian artery
9. 16:40 - 16:45
  
  Endovascular and hybrid aortic arch operations: A single center experience
10. 16:45 - 16:50
  
  Spinal cord ischemia: The most challenging complication in complex aortic surgery. Is intraoperative neuromonitoring a useful tool in the intraoperative decision making to minimize paraplegia?
11. 16:50 - 16:55
  
  Aortic transection – a case series
12. 16:55 - 17:00
  
  Discussion and conclusion
16:15 - 18:00, Main Arena 2

Pioneering techniques and challenges in Thoracoabdominal Aortic Aneurysms (TAAA) repair

Moderator:

Giovanni Torsello, Eric Verhoeven

Panel:

Piotr Kasprzak, Tilo Kölbel, Martin Austermann, Daniela Branzan, Frank Veith
1. 16:15 - 16:20
  
  F/B-EVAR: Ancillary devices and techniques
2. 16:20 - 16:25
  
  VBX as fenestrated/branched bridging stent. EXPAND and personal clinical experience, our key learnings
3. 16:25 - 16:30
  
  Outcomes of Advanta V12 covered stents after fenestrated endovascular aneurysm repair – the BUTTERFLY study
4. 16:30 - 16:35
  
  Treatment via relining with V12 Advanta covered stents of dissolving PTFE covered stents after B/FEVAR
5. 16:35 - 16:40
  
  Bridging from off to on-label in BEVAR
6. 16:40 - 17:05
  
  Live case transmission from Paris
7. 17:05 - 17:10
  
  Preliminary clinical and radiologic outcome of matched patients with thoracoabdominal aortic aneurysms treated by low-profile vs. standard profile branched aortic endografts
8. 17:10 - 17:15
  
  Transfemoral access for branched EVAR has become the new standard
9. 17:15 - 17:20
  
  Value of steerable sheaths and multiport sheaths in complex endovascular aortic repair
10. 17:20 - 17:25
  
  Stability of steerable sheaths for branched EVAR: A bench comparison
11. 17:25 - 17:30
  
  TAAA open repair and organ protection: The 2022 update
12. 17:30 - 17:35
  
  Combined open and endovascular solutions for complex thoraco abdominal aortic aneurysms
13. 17:35 - 17:40
  
  Hybrid thoracoabdominal repair with the Thoracoflow prosthesis: Early experience
14. 17:40 - 17:45
  
  Open branch in BEVAR is a valid option to prevent postoperative paraplegia
15. 17:45 - 17:50
  
  Preoperative embolization of segmental arteries for protection from spinal ischemia after EVAR – results and perspectives
16. 17:50 - 17:55
  
  Is CO2 angiography for EVAR and fEVAR treament efficient?
17. 17:55 - 18:00
  
  Discussion and conclusion
16:25 - 18:00, Main Arena 1

VIVA@LINC – CLTI from challenges to milestones and what is next? – Part II: New interventional approaches in CLTI

Moderator:

Peter Schneider, Marianne Brodmann

Panel:

Luis Palena, Venita Chandra, Koen Deloose, Ralf Langhoff, Roberto Ferraresi
1. 16:25 - 16:50
  
  Live case transmission from Kingsport, USA
2. 16:50 - 16:55
  
  How BTK alternative access techniques have changed my practice
3. 16:55 - 17:00
  
  Specialty balloons and atherectomy for BTK application: How to apply these for optimal lumen gain
4. 17:00 - 17:05
  
  Drug-coated balloons BTK: What is the evidence for Paclitaxel? What is the status of limus-based DCB?
5. 17:05 - 17:30
  
  Live case transmission from Leipzig
6. 17:30 - 17:35
  
  Current and future BTK scaffolds: Tacks, stents, and other novel scaffolds for BTK application
7. 17:35 - 17:40
  
  Alternative bypass techniques: Endovascular deep venous arterialization and detour procedures – where are we so far?
8. 17:40 - 18:00
  
  Discussion

Conference day 4

Thursday, June 9th 2022

8:00 - 9:15, Main Arena 1

CONNECT THE WORLD SESSION in collaboration with JET – peripheral wiring techniques for CTO lesions

partially supported by Asahi Intecc

Moderator:

Roberto Ferraresi

Co-Moderator:

Hiroyoshi Yokoi

Panel:

Yoshimitsu Soga, Daniel van den Heuvel, Steven Kum, Koen Deloose

live from Amagasaki and Abano Terme:

Osamu Iida, Marco Manzi
1. FLASH PRESENTATION: Current status of CLTI
2. Live case transmission from Amagasaki
3. Live case transmission from Abano Terme
4. FLASH PRESENTATION: Antegrade wire escalation for BTK lesions
5. Live case transmission from Amagasaki
6. Live case transmission from Abano Terme
7. FLASH PRESENTATION: Distal puncture and retrograde looping wire technique
8. Live case transmission from Amagasaki – summary
9. Live case transmission from Abano Terme – summary
8:00 - 9:15, Main Arena 2

Endovascular aortic repair for acute aortic syndroms

Moderator:

Vicente Riambau, Stéphan Haulon

Panel:

Weiguo Fu, Dittmar Böckler, Santi Trimarchi, Daniela Branzan
1. 08:00 - 08:05
  
  Aortic remodeling and long-term success in the treatment of complicated dissections
2. 08:05 - 08:35
  
  Live case transmission from Hamburg
3. 08:35 - 08:40
  
  FIRST TIME DATA RELEASE: Differences in mid-term outcomes between patients undergoing endovascular aortic repair for aneurysm or acute and chronic aortic syndromes: Report from GREAT
4. 08:40 - 08:45
  
  10-year clinical outcome and experience of TBAD patients with TEVAR in Shanghai Zhongshan Hospital
5. 08:45 - 08:50
  
  Is distal oversizing the sole cause for distal stent graft-induced new entry in TEVAR?
6. 08:50 - 08:55
  
  Low distal radial force TEVAR devices to prevent SINE
7. 08:55 - 09:00
  
  Treatment of PAU with a balloon expandable covered stent – a multi-center experience
8. 09:00 - 09:05
  
  Preventing aortic remodeling post-Type A aortic dissection repair
9. 09:05 - 09:10
  
  The role of 3D printing in the treatment of urgent complex aortic pathologies
10. 09:10 - 09:15
  
  Discussion and conclusion
8:30 - 9:45, Speakers Corner

Latest results from clinical trials and innovations: EVAR

Moderator:

Giovanni Torsello, Piotr Kasprzak
1. 08:30 - 08:35
  
  Gender differences in proximal neck anatomy and their consequences in patients with abdominal aortic aneurysms
2. 08:35 - 08:40
  
  E-xtra DESIGN multibranch stent grafts in the treatment of thoracoabdominal aneurysms: Early results of the CONNECT investigation
3. 08:40 - 08:45
  
  Multilayer flow modulator stent for aortic pathology: A single-centre retrospective cohort study
4. 08:45 - 08:50
  
  Cardiac plug – dissection stent configuration (Caulking technique) A new configuration for treatment of sub-acute Type B aortic dissection
5. 08:50 - 08:55
  
  Deployment system to deliver a novel adhesive patch to treat aortic dissections
6. 08:55 - 09:00
  
  ANEUFIX, a novel treatment for Type 2 endoleak: Multicenter pivotal trial of technical success, safety and clinical benefit, first results
7. 09:00 - 09:05
  
  Computed tomography-applied software guided early detection of junctional separation between aortic endograft components
8. 09:05 - 09:10
  
  Our initial experience with the novel thoracic Ankura stent graft
9. 09:10 - 09:45
  
  Discussion and conclusion
9:00 - 10:00, Scientific Posters

Moderated poster round – Original research: AV, Carotid, Venous, Visceral

Juror:

Matteo Tozzi, Tobias Steinke
1. 09:00 - 09:05
  
  Outcome of follow up program for detection and treatment of failing AV ACESS in chronic kidney disease patients
2. 09:05 - 09:10
  
  The secondary patency after patch venoplasty vs. balloon venoplasty in management of neointimal hyperplasia of the venous anastomosis of thrombosed arterio-venous grafts for hemodialysis
3. 09:10 - 09:15
  
  A single-center experience of percutaneous arteriovenous fistula creation with the WavelinQ™ 4Fr EndoAVF system. A retrospective analysis of 30 patients
4. 09:15 - 09:20
  
  Association between masseter muscle area and thickness and outcome after carotid endarterectomy: A retrospective cohort study
5. 09:20 - 09:25
  
  AngioJet and Aspirex thrombectomy vs. thrombolysis for acute iliofemoral deep vein thrombosis A multi-center retrospective comparative evaluation of three therapeutic interventional modalities
6. 09:25 - 09:30
  
  Predictive factors of venous stenting failure: A systematic review
7. 09:30 - 09:35
  
  2ry prophylaxis of deep vein thrombosis in pregnancy – PVTP-EGYPT 2020
8. 09:35 - 09:40
  
  Dedicated venous stent in chronic venous disease: Single centre experience
9. 09:40 - 09:45
  
  Randomized prospective comparative study of platlet-rich plasma vs. conventional compression in treatment of post-phlebitic venous ulcer
10. 09:45 - 09:50
  
  Microwave ablation of varicose veins – early Egyptian experience
11. 09:50 - 09:55
  
  Endovascular management of visceral aneurysms: Our results with different techniques
12. 09:55 - 10:00
  
  Draft for a disease-severity score in aortoiliac occlusive disease: The A.C.H.EL.I.S ACE score
9:15 - 10:30, Main Arena 1

Limb preservation masterclass: Cutting edge techniques and tools for CLTI

supported by COOK Medical

Moderator:

Jos van den Berg

Panel:

Marianne Brodmann, Marco Manzi
1. 09:15 - 09:40
  
  Live case transmission from Leipzig
2. 09:40 - 09:53
  
  The cost of endovascular limb preservation vs. amputation
3. 09:53 - 10:06
  
  The antegrade approach to CLTI and advanced CTO crossing strategies
4. 10:06 - 10:19
  
  Pedal artery revascularisation: The retrograde approach to CLTI and advanced CTO crossing strategies
5. 10:19 - 10:30
  
  Q&A, discussion, and conclusion
9:15 - 9:50, Main Arena 2

CONNECT THE WORLD SESSION: Innovations in endovascular thoraco abdominal aortic repair

supported by Lifetech

Moderator:

Vicente Riambau, Chang Shu

Panel:

Ralf Kolvenbach, Marwan Youssef
1. 09:15 - 09:30
  
  Recorded case presentation from Beijing – G-Branch for endovascular repair of TAAA
2. 09:30 - 09:37
  
  Application of fenestration technique in aortic arch disease
3. 09:37 - 09:44
  
  A new adjustable puncture device for in situ fenestration during thoracic endovascular aortic repair
4. 09:44 - 09:50
  
  Discussion and conclusion
9:50 - 11:05, Main Arena 2

Latest techniques and technologies for TEVAR in the aortic arch

partially supported by Artivion

Moderator:

Tilo Kölbel, Mario Lachat

Panel:

Wei Guo, Theodosios Bisdas
1. 09:50 - 10:15
  
  Live case transmission from Leipzig Heart Center
2. 10:15 - 10:20
  
  Nexus Aortic Arch System: Tips and tricks for addressing complex cases
3. 10:20 - 10:25
  
  The TRIOMPHE study – NEXUS Aortic Arch FDA clinical study
4. 10:25 - 10:30
  
  Emergency treatment in arch pathologies
5. 10:30 - 10:35
  
  Can a single branch approach significantly mitigate stroke risks? A 28-patient series seems to suggest so
6. 10:35 - 10:40
  
  Guo's aortIc arch recoNsTruction: The prospective, multiple center study about the safety and efficacy of WeFlow-Arch™ stent graft system (GIANT study)
7. 10:40 - 10:45
  
  A complete percutaneous technique for three-branched arch TEVAR
8. 10:45 - 10:50
  
  In situ fenestration as an alternative to branched aortic arch devices
9. 10:50 - 10:55
  
  Fenestrated arch TEVAR: When to use it
10. 10:55 - 11:00
  
  Hybrid repair still remains a good option for aortic arch pathology
11. 11:00 - 11:05
  
  Extra-anatomic bypass for recurrent aortic coarctation
10:15 - 11:15, Speakers Corner

Challenging cases and complications: EVAR – Part II

Moderator:

Spiridon Botsios, Luca Bertoglio
1. 10:15 - 10:20
  
  Mycotic aortic aneurysm rupture exposing the spine
2. 10:20 - 10:25
  
  Rupture of right common iliac artery related to a spinal osteophyte
3. 10:25 - 10:30
  
  Modified extended petticoat technique for the treatment of a giant false lumen iliac aneurysm following an acute Type B aortic dissection: A case report
4. 10:30 - 10:35
  
  A complex thoracoabdominal aortic aneurysm managed by endovascular grafts and four chimneys
5. 10:35 - 10:40
  
  Hybrid open and endovascular treatment of an erosion of elephant trunk prosthesis in a patient with symptomatic abdominal aortic aneurysm
6. 10:40 - 10:45
  
  Endovascular repair of a ruptured common iliac aneurysm in the presence of a persistent sciatic artery (and a horseshoe kidney)
7. 10:45 - 10:50
  
  Fenestrated endo-vascular aneurysm repair gone wrong: An interesting worst case
8. 10:50 - 10:55
  
  Double barrel plugging in recurrent aorto-enteric fistula
9. 10:55 - 11:00
  
  Treatment of Type 1A endoleak using laser fenestration of an endograft to the LSA
10. 11:00 - 11:05
  
  Initial experience in the treatment of thoracic aortic pathology with the new Lifetech Ankura stent graft
11. 11:05 - 11:15
  
  Discussion and conclusion
10:30 - 11:15, Main Arena 1

New techniques and technologies for BTK interventions – latest data

Moderator:

Marianne Brodmann, Steven Kum

Panel:

Tatsuya Nakama, Francesco Liistro, Yoshimitsu Soga, Luis Palena, Michael Lichtenberg
1. 10:30 - 10:35
  
  Live case recap from first session
2. 10:35 - 10:40
  
  ACOART-BTK: 3-year clinical outcome
3. 10:40 - 10:45
  
  Current status and future of limus based drug coated balloons in the infrapopliteal arteries
4. 10:45 - 10:50
  
  Latest evidence for focal dissection repair with the Tack endovascular scaffold: Reviewing the 2-year TOBA II BTK data
5. 10:50 - 10:55
  
  When to stent tibial arteries: Update on abluminus sirolimus eluting stent trial
6. 10:55 - 11:00
  
  SAVAL DESK BTK: Current status
7. 11:00 - 11:05
  
  Current technology for BTK scaffolds
8. 11:05 - 11:10
  
  Bioresorbable scaffolds for BTK interventions (LIFE-BTK)
9. 11:10 - 11:15
  
  R3 vascular drug-eluting bioresorbable scaffold in below the knee vessels: Interim results from the RESOLV-I trial
11:05 - 12:30, Main Arena 2

Endovascular repair of the thoracic aorta – current techniques

Moderator:

Vicente Riambau, Theodosios Bisdas

Panel:

Marc van Sambeek, Stephen Cheng, Dittmar Böckler, Giovanni Torsello
1. 11:05 - 11:10
  
  Early clinical experience with the new Ankura Thoracic stent graft
2. 11:10 - 11:15
  
  Initial experience using in-situ-fenestration of the aortic arch pathologies
3. 11:15 - 11:20
  
  Validation of TEVAR results across multiple diseases: A French experience
4. 11:20 - 11:25
  
  Management and treatment of patients with blunt trauma aortic injury: 5-year results from the RESCUE trial
5. 11:25 - 11:55
  
  Live case transmission from Paris
6. 11:55 - 12:00
  
  Long-term TEVAR performance in the dynamic TAA pathology
7. 12:00 - 12:05
  
  Current trends in reduction or elimination of rapid pacing during stent-graft deployment
8. 12:05 - 12:10
  
  Endoanchor applicability in TEVAR
9. 12:10 - 12:15
  
  Stroke rate after thoracic endovascular aortic repair using de-airing of stentgrafts with high-volume of saline solution
10. 12:15 - 12:20
  
  Prevention of air-embolism using carbondioxide flushing: What is the evidence?
11. 12:20 - 12:30
  
  Discussion and conclusion
11:15 - 12:30, Main Arena 1

SYMPOSIUM: Redefining vascular treatment strategy for AVF and AVG: A deep dive into Sirolimus coated balloon

supported by Concept Medical

Moderator:

Tjun Tang

Panel:

Edward Choke, Gireesh Reddy, Chieh Suai Tan, Sanjay Misra
1. 11:15 - 11:27
  
  Advantages of Sirolimus over Paclitaxel for the treatment of AVF/AVG Stenosis
2. 11:27 - 11:37
  
  MATILDA 2 year follow up presentation and case presentation
3. 11:37 - 11:44
  
  Complex cases presentation AVG
4. 11:44 - 11:51
  
  2 year follow up on AVF in salvage of AVG study
5. 11:51 - 11:58
  
  Updates on IMPRESSION RCT and study design presentation
6. 11:58 - 12:05
  
  Complex cases presentation AVF
7. 12:05 - 12:12
  
  Magic Touch AVF – US FDA Study Design
8. 12:12 - 12:27
  
  Panel discussion
9. 12:27 - 12:30
  
  Conclusion
11:15 - 12:30, Speakers Corner

Latest clinical data and original research papers: EVAR – Part I

Moderator:

Reza Ghotbi
1. 11:15 - 11:20
  
  Optimal timing of TEVAR for Type B aortic dissections: A systematic review and meta-analysis
2. 11:20 - 11:25
  
  Modern endovascular aneurysm repair offers a survival advantage and is cost-effective compared to conservative management in patients physiologically unfit for open surgical aneurysm repair
3. 11:25 - 11:30
  
  Midterm outcomes of endovascular treatment for infected aortic aneurysms: Single center experience
4. 11:30 - 11:35
  
  Meta-analysis of the crossed vs. standard limb configuration in endovascular aneurysm repair
5. 11:35 - 11:40
  
  Elusive endoleaks: What scan will stop a rupture?
6. 11:40 - 11:45
  
  Preliminary results from an Italian national registry on the outcomes of the semi-custom-made Najuta fenestrated aortic arch endograft
7. 11:45 - 11:50
  
  Embolization of the lumbar arteries before EVAR: A prospectively randomized trial comparing platinum-fibered microcoils (control arm) with the MVP. microvascular plug (study arm)
8. 11:50 - 11:55
  
  Ultrasound-guided vs. conventional MANTA vascular closure device deployment after transcatheter aortic valve replacement
9. 11:55 - 12:00
  
  Occlusion of an existing wide and patent IMA prior to EVAR may contribute to the development of post-EVAR fever
10. 12:00 - 12:05
  
  Comparison of a steerable sheath in exclusively femoral access vs. upper extremity access in branched endovascular aortic repair
11. 12:05 - 12:10
  
  Impact of vascular access site complications for long-term mortality after transfemoral transcatheter aortic valve implantation (tf-TAVI) in a real-world setting
12. 12:10 - 12:15
  
  The evolving management of ruptured abdominal aortic aneurysms: An Australian centre experience
13. 12:15 - 12:20
  
  The versatile altura aortic endograft demonstrates excellent 5 year outcomes
14. 12:20 - 12:25
  
  Early outcomes of a new generation covered stent in branched endovascular repair of thoracoabdominal aneurysms
15. 12:25 - 12:30
  
  Discussion and conclusion
12:30 - 13:25, Main Arena 1

LUNCH SYMPOSIUM: Innovations and new applications of embolization therapies

Moderator:

Walter A. Wohlgemuth, Romaric Loffroy

Panel:

Costantino del Giudice, Gloria Salazar, Clifford Weiss, Manuela Konert
1. 12:30 - 12:35
  
  Management of endoleaks via transarterial embolization with Onyx 34L
2. 12:35 - 12:40
  
  Contemporary peripheral aneurysm management: Techniques with fibered coils and micro vascular plugs
3. 12:40 - 12:50
  
  Recorded case presentation
4. 12:50 - 12:55
  
  French SEAL registry: Type II EndoLeak treatment outcomes using EVOH
5. 12:55 - 13:00
  
  Pulmonary AVMs: Deep dive into new data and guideline updates
6. 13:00 - 13:05
  
  Using liquids in trauma cases: Application of Onyx LES
7. 13:05 - 13:10
  
  Embolic selection for hemorrhoids: New application for coil technology
8. 13:10 - 13:15
  
  The CHRYSALIS study: First experience with the Caterpillar embolization device
9. 13:15 - 13:25
  
  Discussion and conclusion
12:30 - 13:15, Main Arena 2

LUNCH SYPOSIUM: Advancing procedures in complex aortic repair

supported by Philips

Moderator:

Bijan Modarai

Panel:

Qasam M. Ghulam, Geert Willem Schurink, Barend Mees
1. 12:30 - 12:35
  
  Introduction by the moderator
2. 12:35 - 12:45
  
  Improving outcomes of complex aortic procedures using advanced imaging techniques
3. 12:45 - 12:48
  
  Q&A, discussion
4. 12:48 - 12:58
  
  Improving AAA measurement accuracy using innovative Ultrasound 3D volume model automation and xMATRIX
5. 12:58 - 13:01
  
  Q&A, discussion
6. 13:01 - 13:11
  
  The use of Fiber Optic RealShape (FORS) technology in various aortic interventions
7. 13:11 - 13:15
  
  Q&A, discussion, and conclusion
13:30 - 15:00, Main Arena 1

A comprehensive look at CLTI treatment: New approaches for assessment of CLTI and pioneering options for “No-hope-patients” – part I

Moderator:

Jos van den Berg, Marianne Brodmann

Panel:

Jihad Mustapha, William Gray, Roberto Ferraresi, Eric Ducasse, Peter Goverde
1. 13:30 - 13:35
  
  Hemodynamic vs. anatomical diagnosis of CLI
2. 13:35 - 13:55
  
  Live case transmission from Abano Terme – part I
3. 13:55 - 14:00
  
  Different types of atherosclerosis of the tibial arteries: Learn the histopathology
4. 14:00 - 14:05
  
  The role of vascular recoil in tibial arteries – the concept of the Choco Cabana study
5. 14:05 - 14:10
  
  Angiolite BTK trial: 2-year data in CLTI
6. 14:10 - 14:15
  
  Biblios trial: Investigating the safety and efficacy of the Luminor 14 DCB in the treatment of BTK lesions in real CLTI patients: Preliminary data (first 100 patients)
7. 14:15 - 14:20
  
  Remaining place for distal bypasses in BTK area
8. 14:20 - 14:40
  
  Live case transmission from Abano Terme – part II
9. 14:40 - 14:45
  
  Initial experience with the Microstent in tibial arteries – insights from the STAND trial
10. 14:45 - 14:50
  
  The Novel Temporary Spur stent system used in conjunction with a commercially available Paclitaxel balloon: 6-month results of the Deeper OUS trial
11. 14:50 - 14:55
  
  Dissection analysis after BTK-intervention with the Serranator device: A core-lab adjudicated study
12. 14:55 - 15:00
  
  CLTI – vascular recurrence. How to monitor and when to re-intervene
13:30 - 14:30, Main Arena 2

Aortic controversies – preservation as a standard of care: Achieving a durable EVAR outcome in a compromised iliac seal zone

partially supported by W. L. Gore & Associates

Moderator:

Konstantinos Donas

Panel:

Jan Heyligers, Mauro Gargiulo, Jorge Fernández Noya
1. Does preservation always matter? When is it important to maintain flow to both IIA?
2. Live case transmission from Leipzig
3. When to use a limb instead of an iliac branched device?
4. Dynamic CT evaluation of iliac branched devices
5. Advanced concepts for treating the diseased hypograstric – does the data support it?
13:30 - 14:45, Speakers Corner

Latest clinical data and original research papers: EVAR – Part II

Moderator:

Daniela Branzan, Theodosios Bisdas
1. 13:30 - 13:35
  
  Blunt traumatic aortic injury: The 20 year experience of a large trauma referral hospital
2. 13:35 - 13:40
  
  Finding the appropriate technique for planning the stent-graft lengths in PRETEVAR CT
3. 13:40 - 13:45
  
  Inner-branched endograft in challenging treatment of complex secondary aortic intervention in case of abdominal and thoraco-abdominal aneurysmal progression: A retrospective single center study
4. 13:45 - 13:50
  
  Endovascular preservation of segmental arteries during treatment of thoracoabdominal aortic aneurysm with fenestrated/branched stent-grafts: Feasibility and outcome
5. 13:50 - 13:55
  
  Stroke, spinal cord ischemia, and upper limb ischemia in patients undergoing TEVAR with coverage of the left subclavian artery: A case series study
6. 13:55 - 14:00
  
  The necessity to seal the re-entry tears of aortic dissection after TEVAR: A hemodynamic indicator
7. 14:00 - 14:05
  
  The use of high-fidelity simulators in assessing endovascular surgical competence
8. 14:05 - 14:10
  
  Systematic review and meta-analysis of thoracic endovascular aortic repair of Type B aortic dissection in mainland China
9. 14:10 - 14:15
  
  Spinal cord ischemia prevention through hypogastric and inferior mesenteric artery preservation during complex endovascular aortic procedures
10. 14:15 - 14:20
  
  Abdominal aortic aneurysm sac healing with a bioabsorable shape memory polymer
11. 14:20 - 14:45
  
  Discussion and conclusion
14:30 - 15:15, Main Arena 2

CONNECT THE WORLD : Novel and well-engineered stent grafts tailored for abdominal aortic repair

supported by Shanghai MicroPort Endovastec

Moderator:

Weiguo Fu, Alexander Zimmermann

Panel:

Nilo Mosquera, Raghuram Lakshminarayan
1. 14:30 - 14:32
  
  Introduction
2. 14:32 - 14:42
  
  An Optimal EVAR Solution: MINOS ultra-low profile stent graft in abdominal aortic repair and its latest clinical data
3. 14:42 - 14:52
  
  Real world experience with the ultra-low profile MINOS device
4. 14:52 - 15:02
  
  Recorded case with MINOS for treatment of AAAs with challenging anatomy
5. 15:02 - 15:12
  
  Ultra-low profile Fenestrated Altura: Early clinical experience in Europe
6. 15:12 - 15:15
  
  Discussion and conclusion
15:00 - 15:45, Main Arena 1

SYMPOSIUM: WavelinQ™ EndoAVF System: An innovative patient centric solution

supported by BD

Moderator:

Tobias Steinke

Panel:

Panagiotis Kitrou, Ounali Jaffer, Fien Gryffroy
1. 15:00 - 15:07
  
  WavelinQ™ EndoAVF global clinical program, new and available evidence
2. 15:07 - 15:14
  
  Recorded case with WavelinQ™ EndoAVF System: The antiparallel option
3. 15:14 - 15:21
  
  Recorded case with WavelinQ™ EndoAVF System: The parallel option
4. 15:21 - 15:28
  
  Secondary procedures on EndoAVF: A practical approach
5. 15:28 - 15:45
  
  Panel discussion
15:15 - 16:30, Main Arena 2

Repair options for chronic aortic dissections

Moderator:

Bijan Modarai, Luca Bertoglio

Panel:

Eric Verhoeven, Armando Lobato, Weiguo Fu, Patricia Rodríguez Cabeza
1. 15:15 - 15:20
  
  The natural history of chronic aortic dissections with and without TEVAR: Implications for repair considerations
2. 15:20 - 15:25
  
  How to handle specific anatomies in PDTAAA
3. 15:25 - 15:30
  
  The Zenith TX2 dissection endovascular graft: Results of a dedicated dissection stent-graft from a European registry
4. 15:30 - 15:35
  
  GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis: First European clinical experience
5. 15:35 - 16:00
  
  Live case transmission from Hamburg
6. 16:00 - 16:05
  
  Results of false lumen occlusion using the Candy-Plug: A European experience
7. 16:05 - 16:10
  
  Symptomatic aneurysm of the left subclavian artery’s ostium. Endovascular technique with CERA plug
8. 16:10 - 16:15
  
  The Lobato technique for acute Type B aortic dissection complicated with thoracoabdominal aortic aneurysm and total true lumen occlusion of the infrarenal aorta
9. 16:15 - 16:20
  
  Endovascular repair options in chronic aortic dissection
10. 16:20 - 16:30
  
  Discussion and conclusion
15:45 - 17:30, Main Arena 1

A comprehensive look at CLTI treatment: New approaches for assessment of CLTI and pioneering options for “No-hope-patients” – part II

Moderator:

Peter Schneider, Arne Schwindt

Panel:

Steven Kum, Roberto Ferraresi, Miguel Montero-Baker, Katja Mühlberg
1. FOCUS ON DEEP VENOUS ARTERIALIZATION
2. 15:45 - 15:50
  
  UCSF no-option patient identification rational and experience
3. 15:50 - 15:55
  
  Latest insights on DVA mechanism of action
4. 15:55

Notice

LINC 2022 Programme

LINC 2022 programme

Conference day 1

New solutions for complex aortoiliac obstructions

Live case transmission from Leipzig – part I

Use and effectiveness of Pioneer re-entry device for subintimal true lumen re-entry: Single-centre data and a review of the literature

Initial interim results from the post-market registry of the GORE® VIABAHN® VBX balloon expandable endoprosthesis implanted in peripheral vessels

Following up patients with iliac occlusive disease treated with the GORE® VIABAHN® VBX balloon expandable endoprosthesis – FLEX clinical study

Outcomes of self-expanding e-PTFE covered stent when treating chronic iliac artery occlusions – a multi-centre experience

Live case transmission from Leipzig – part II

Versatility of covered stents in complex aorto-iliac POD lesions and FEVAR/BEVAR

FIRST TIME DATA RELEASE: BELSTREAM – 12-month results of study

5-year follow-up of CERAB reconstructions: Single center experience from the Netherlands

Multicentre experience on CERAB technique for the treatment option of AIOD – Polish experiences

Improving outcomes of vascular interventions with AI

Advances in intravascular imaging: Real world evidence and expert consensus

Carotid revascularisation – what is new in 2022?

Quality assessment of carotid reconstruction – anything new from the German registry?

ACST II-trial: Update on latest data and clinical implications

Proximal protection in CAS: the right way to go?

Improving your safety profile through proximal protection: Experiences from a high volume carotid artery stenting center

Live case transmission from Milan

TCAR: Patient selection, technique, and role in contemporary practice

CAS in patients with bovine and Type III arch – a single center experience

Carotid stenosis treatment: Is the puzzle complete?

Introduction

Asymptomatic carotid stenosis treatment: Lessons from > 6000 randomized patients in AST 1 and 2

Live case transmission from Münster

ROADSAVER study outcomes: Real-world evidence from a large carotid stenting cohort treated with a dual-layer micromesh stent

Live in a box from Milan

Pieces of puzzle coming together, building a new carotid treatment algorithm

Q&A, discussion, and conclusion

Opening Symposium: Focus on the lower limb: Novel treatment options from SFA to BTK

Welcome from the moderator

Late breaker: 2 year follow-up of SUPERSUB II

Discussion

THROMBECTOMY: THE BENEFITS OF MECHANICAL THROMBECTOMY FOR LOWER LIMB TREATMENT

Treating acute limb ischemia with mechanical thrombectomy – case presentation

Mechanical thrombectomy for venous thromboembolism: A pathway to consider?

Treating venous thromboembolism with mechanical thrombectomy – case presentation

Discussion

Tomorrow’s BTK treatment options – drug eluting resorbable scaffolds

Discussion

Take-home messages

Novel approaches and insights for treatment of complex femoropopliteal disease – part I

Serration angioplasty technique for better lumen gain

RECORDED CASE PRESENTATION: Serranator Serration balloon as primary therapy for CLTI disease

FIRST TIME DATA RELEASE: UltraScore – final results of a multi-center study

FIRST TIME DATA RELEASE: Long-term evidence of directonal atherectomy and DCB: 3-year clinical experience from Australia

Clinical outcomes with drug-coated balloon alone vs. drug-coated balloon plus provisional stenting: An analysis from the IN.PACT global study 5-year data

BIOPACT RCT: A head-to-head multicenter noninferiority trial of the safety and efficacy of Passeo-18 Lux vs. In.Pact Admiral DCBs in fempop lesions

Live case transmission from Bad Krozingen

FIRST TIME DATA RELEASE: Cost-effectiveness of urea excipient-based drug-coated balloons for chronic limb-threatening ischemia from femoropopliteal disease

5-year results from the Lutonix trial

IN.PACT global study 5-year diabetic and gender subgroup outcomes

Recent data outcomes in complex femoropopliteal occlusive disease with the GORE® VIABAHN® Endoprosthesis

Innovative options for patients with end-stage renal disease: Percutaneous creation of AV-access

Multi-center experience with WavelinQ™ 4F in 120 patients

Patient perspective of EndoAVF – insights from a multi-center analysis

Single-center experience with WavelinQ™ 4F

Implications of anatomic variations for EndoAVF

AVF creation using Ellipsys: Long-term evidence to date

AVF creation: Comparing surgical and percutaneous outcomes

FIRST TIME DATA RELEASE: Arteriovenous access creation: Updates from the Hamburg experience

Are we stenting too little, too late? An introduction to the WRAPSODY™ cell-impermeable endoprosthesis and 12-month data

Introduction by the moderator

The evolution of covered stents

Live case transmission from Varese

Clinical trials: WRAPSODY™ FIRST, IDE, and registry

Recorded case presentation

The algorithm for covered stent treatment

Health economics in covered stent management: An overview

Final Q&A and wrap up

Latest results from clinical trials and innovations: Carotid/Venous/AV

30-day safety outcomes of patients treated with the Roadsaver dual-layer micromesh carotid artery stent via radial or femoral access route: Evidence from a large multicentre European study (ROADSAVER)

Intravascular lithotripsy (IVL) as new tool in calcified carotid arteries stenosis. Single center experience – LITO–ARCH registry

30-day safety outcomes of patients <75 and ≥75 years of age treated with the Roadsaver dual-layer micromesh carotid artery stent: Evidence from a large multicentre European study (ROADSAVER)

Randomized controlled trial of a first-generation carotid stent vs. the micronet-covered stent: 12-month outcomes

Mechanical thrombectomy for deep vein thrombosis in real-world patients: 6-month outcomes from the CLOUT registry